<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.1.0//EN//XML" "art510.dtd" []><article docsubtype="rev"><item-info><jid>PCL</jid><aid>729</aid><ce:pii>S0031-3955(10)00042-8</ce:pii><ce:doi>10.1016/j.pcl.2010.02.008</ce:doi><ce:copyright type="full-transfer" year="2010">Elsevier Inc.</ce:copyright></item-info><ce:floats><ce:table id="tbl1" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 1</ce:label><ce:caption><ce:simple-para>Manufacturers&apos; claims of ergogenic agents</ce:simple-para></ce:caption><tgroup cols="1"><colspec colnum="1" colname="col1"/><tbody><row valign="top"><entry>Serve as an energy source</entry></row><row valign="top"><entry>Decrease fatigue in sports events</entry></row><row valign="top"><entry>Increase lean body mass and strength</entry></row><row valign="top"><entry>Decrease adipose tissue</entry></row><row valign="top"><entry>Alter weight in desirable directions</entry></row><row valign="top"><entry>Improve aerobic capacity</entry></row><row valign="top"><entry>Enhance motor capacity</entry></row><row valign="top"><entry>Improve appearance</entry></row><row valign="top"><entry>Enhance overall sports performance</entry></row></tbody></tgroup></ce:table><ce:table id="tbl2" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 2</ce:label><ce:caption><ce:simple-para>Drugs misused by athletes as ergogenic products</ce:simple-para></ce:caption><tgroup cols="1"><colspec colnum="1" colname="col1"/><tbody><row valign="top"><entry>&alpha;-Lipoic acid</entry></row><row valign="top"><entry>Anabolic steroids (DHEA, androstenedione)</entry></row><row valign="top"><entry>Antioxidants (vitamin C, vitamin E, &beta;-carotene)</entry></row><row valign="top"><entry>Amphetamines</entry></row><row valign="top"><entry>Bee pollen</entry></row><row valign="top"><entry>&beta;-blockers (ie, propranolol)</entry></row><row valign="top"><entry>&beta;-Hydroxy-&beta;-methylbutyrate</entry></row><row valign="top"><entry>Blood</entry></row><row valign="top"><entry>Caffeine</entry></row><row valign="top"><entry>Calcium</entry></row><row valign="top"><entry>Carnitine</entry></row><row valign="top"><entry>Choline</entry></row><row valign="top"><entry>Chrysin</entry></row><row valign="top"><entry>Chromium</entry></row><row valign="top"><entry>Clenbuterol</entry></row><row valign="top"><entry>Coenzyme Q<ce:inf>10</ce:inf></entry></row><row valign="top"><entry>Creatine</entry></row><row valign="top"><entry>DSMO</entry></row><row valign="top"><entry>Diuretics (furosemide, spironolactone, hydrochlorothiazide)</entry></row><row valign="top"><entry>Engineered dietary supplements</entry></row><row valign="top"><entry>Ephedrine</entry></row><row valign="top"><entry>EPO</entry></row><row valign="top"><entry>Folic acid</entry></row><row valign="top"><entry>Ginkgo biloba</entry></row><row valign="top"><entry>Ginseng</entry></row><row valign="top"><entry>Glycerol</entry></row><row valign="top"><entry>hGH</entry></row><row valign="top"><entry>Inosine</entry></row><row valign="top"><entry>IGF-I</entry></row><row valign="top"><entry>Iron</entry></row><row valign="top"><entry>Minerals:<ce:br/><ce:hsp sp="1"/>Boron<ce:br/><ce:hsp sp="1"/>Chromium<ce:br/><ce:hsp sp="1"/>Vanadium<ce:br/><ce:hsp sp="1"/>Iron<ce:br/><ce:hsp sp="1"/>Selenium<ce:br/><ce:hsp sp="1"/>Zinc</entry></row><row valign="top"><entry>Niacin</entry></row><row valign="top"><entry>Nicotine</entry></row><row valign="top"><entry>Nonsteroidal antiinflammatory drugs (ibuprofen, mefenamic acid, naproxen, others)</entry></row><row valign="top"><entry>Omega-3 fatty acids</entry></row><row valign="top"><entry>Oxygen</entry></row><row valign="top"><entry>Pantothenic acid</entry></row><row valign="top"><entry>Phosphorus</entry></row><row valign="top"><entry>Pyridoxine (vitamin B<ce:inf>6</ce:inf>)</entry></row><row valign="top"><entry>Plant steroids (phytosteroids; &gamma;-oryzanol; ferulic acid [FRAC])</entry></row><row valign="top"><entry>Protein supplements</entry></row><row valign="top"><entry>Riboflavin</entry></row><row valign="top"><entry>Sodium bicarbonate</entry></row><row valign="top"><entry>Sport drinks</entry></row><row valign="top"><entry>Thiamin (vitamin B<ce:inf>1</ce:inf>)</entry></row><row valign="top"><entry>Tribulus terrestris</entry></row><row valign="top"><entry>Vitamin supplements</entry></row><row valign="top"><entry>Vitamin B<ce:inf>12</ce:inf> (cyanocobalamin)</entry></row><row valign="top"><entry>Vitamin B<ce:inf>15</ce:inf> (dimethylglycine)</entry></row><row valign="top"><entry>Yohimbine (yohimbe)</entry></row><row valign="top"><entry>Others</entry></row><row valign="top"><entry>Various illicit drugs<ce:br/><ce:hsp sp="1"/>Alcohol. marijuana, tobacco, methamphetamine, cocaine, GHB; GBL<ce:br/><ce:hsp sp="1"/>Hallucinogens (lysergic acid diethylamide and phencyclidine&middot;HCl)<ce:br/><ce:hsp sp="1"/>Barbiturates, opiate narcotics, inhalants (volatile solvents, nitrous oxide, nitrites)</entry></row></tbody></tgroup></ce:table><ce:table id="tbl3" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 3</ce:label><ce:caption><ce:simple-para>Examples of anabolic steroids</ce:simple-para></ce:caption><ce:source><ce:italic>Data from</ce:italic> Greydanus DE. Performance enhancing drugs and supplements In: DR Patel, DE Greydanus, R Baker, editors. Pediatric practice: sports medicine. New York: McGraw-Hill Medical Publishers; 2009. p. 63&ndash;77.</ce:source><tgroup cols="1"><colspec colnum="1" colname="col1"/><tbody><row valign="top"><entry><ce:list><ce:list-item><ce:para>Oral steroids<ce:list><ce:list-item><ce:label>1.</ce:label><ce:para>Oxandrolone (Oxandrin)</ce:para></ce:list-item><ce:list-item><ce:label>2.</ce:label><ce:para>Oxymetholone (Anadrol)</ce:para></ce:list-item><ce:list-item><ce:label>3.</ce:label><ce:para>Stanozolol (Winstrol)</ce:para></ce:list-item></ce:list></ce:para></ce:list-item></ce:list></entry></row><row valign="top"><entry><ce:list><ce:list-item><ce:para>Injectable steroids<ce:list><ce:list-item><ce:label>1.</ce:label><ce:para>Testosterone cypionate (Testim)</ce:para></ce:list-item><ce:list-item><ce:label>2.</ce:label><ce:para>Testosterone enanthate (Depo-Testosterone)</ce:para></ce:list-item><ce:list-item><ce:label>3.</ce:label><ce:para>Nandrolone phenpropionate (Durabolin)</ce:para></ce:list-item><ce:list-item><ce:label>4.</ce:label><ce:para>Nandrolone decanoate (Deca-Durabolin)</ce:para></ce:list-item></ce:list></ce:para></ce:list-item></ce:list></entry></row><row valign="top"><entry><ce:list><ce:list-item><ce:para>Topical steroids<ce:list><ce:list-item><ce:label>1.</ce:label><ce:para>Testosterone gel (Androgel)</ce:para></ce:list-item><ce:list-item><ce:label>2.</ce:label><ce:para>Testosterone transdermal (Androderm)</ce:para></ce:list-item></ce:list></ce:para></ce:list-item></ce:list></entry></row></tbody></tgroup></ce:table><ce:table id="tbl4" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 4</ce:label><ce:caption><ce:simple-para>Anabolic steroids side effects</ce:simple-para></ce:caption><tgroup cols="1"><colspec colnum="1" colname="col1"/><tbody><row valign="top"><entry>Fluid retention</entry></row><row valign="top"><entry>Masculinization of females<ce:br/><ce:hsp sp="1"/>Hirsutism<ce:br/><ce:hsp sp="1"/>Clitoromegaly<ce:br/><ce:hsp sp="1"/>Alopecia (males also)<ce:br/><ce:hsp sp="1"/>Voice deepening</entry></row><row valign="top"><entry>Other changes for females<ce:br/><ce:hsp sp="1"/>Amenorrhea<ce:br/><ce:hsp sp="1"/>Skin coarseness<ce:br/><ce:hsp sp="1"/>Acne (both sexes; can be severe)</entry></row><row valign="top"><entry>Growing athletes:<ce:br/><ce:hsp sp="1"/>Acceleration of maturation<ce:br/><ce:hsp sp="1"/>Early epiphyseal closure<ce:br/><ce:hsp sp="1"/>Shortened ultimate adult height<ce:br/><ce:hsp sp="1"/>Increase in tendon injuries</entry></row><row valign="top"><entry>Psychological changes<ce:br/>See increase in:<ce:br/><ce:hsp sp="1"/>Aggressiveness<ce:br/><ce:hsp sp="1"/>Irritability<ce:br/><ce:hsp sp="1"/>Depression</entry></row><row valign="top"><entry>Gastric ulcers</entry></row><row valign="top"><entry>Liver complications<ce:br/><ce:hsp sp="1"/>Increase in liver function tests<ce:br/><ce:hsp sp="1"/>Cholestasis<ce:br/><ce:hsp sp="1"/>Peliosis hepatitis<ce:br/><ce:hsp sp="1"/>Liver failure<ce:br/><ce:hsp sp="1"/>Benign liver neoplasm<ce:br/><ce:hsp sp="1"/>Malignant liver tumor (hepatocellular carcinoma)</entry></row><row valign="top"><entry>Hyperglycemia (hyperinsulinemia)</entry></row><row valign="top"><entry>Prostatic enlargement (possible increase risk for prostatic cancer)</entry></row><row valign="top"><entry>Decrease in glycoproteins (follicle-stimulating hormone and luteinizing hormone) with:<ce:br/><ce:hsp sp="1"/>Decreased spermatozoa<ce:br/><ce:hsp sp="1"/>Decreased testosterone levels<ce:br/><ce:hsp sp="1"/>Reduction in testicular size</entry></row><row valign="top"><entry>Increase in tendon injuries</entry></row><row valign="top"><entry>Reduction in high density lipoprotein, increased total cholesterol</entry></row><row valign="top"><entry>Increased platelet aggregation, potential rise in cardiovascular disorders</entry></row><row valign="top"><entry>Wilms tumor (at least 1 case report)</entry></row></tbody></tgroup></ce:table><ce:table id="tbl5" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 5</ce:label><ce:caption><ce:simple-para>Banned substances and methods</ce:simple-para></ce:caption><ce:source><ce:italic>Data from</ce:italic> Greydanus DE, Patel DR. Sports doping: use of drugs and supplements to enhance performance. Int Public Health Journal 2009;1(4):2.</ce:source><tgroup cols="2"><colspec colnum="1" colname="col1"/><colspec colnum="2" colname="col2"/><tbody><row valign="top"><entry morerows="4">Main categories of prohibited substances</entry><entry>Anabolic agents</entry></row><row valign="top"><entry>Hormones and related substances (growth hormone, IGF-I, insulin, EPO)</entry></row><row valign="top"><entry>&beta;2 agonists</entry></row><row valign="top"><entry>Hormone agonists and modulators</entry></row><row valign="top"><entry>Diuretics and other masking agents</entry></row><row valign="top"><entry morerows="2">Main categories of prohibited methods</entry><entry>Enhancement of oxygen transfer</entry></row><row valign="top"><entry>Chemical and physical manipulation</entry></row><row valign="top"><entry>Gene doping</entry></row></tbody></tgroup></ce:table><ce:table id="tbl6" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 6</ce:label><ce:caption><ce:simple-para>Drugs banned from various sports competitions</ce:simple-para></ce:caption><tgroup cols="1"><colspec colnum="1" colname="col1"/><tbody><row valign="top"><entry>Anabolic steroids (see <ce:cross-ref refid="tbl3">Table 3</ce:cross-ref>)</entry></row><row valign="top"><entry>Beta blockers<ce:br/><ce:hsp sp="1"/>Clenbuterol<ce:br/><ce:hsp sp="1"/>Metoprolol<ce:br/><ce:hsp sp="1"/>Propranolol</entry></row><row valign="top"><entry>Diuretics<ce:br/><ce:hsp sp="1"/>Furosemide<ce:br/><ce:hsp sp="1"/>Hydrochlorothiazide<ce:br/><ce:hsp sp="1"/>Spironolactone</entry></row><row valign="top"><entry>Narcotics<ce:br/><ce:hsp sp="1"/>Dextropropoxyphene (Darvon)<ce:br/><ce:hsp sp="1"/>Morphine<ce:br/><ce:hsp sp="1"/>Meperidine (Demerol)</entry></row><row valign="top"><entry>Peptide hormones<ce:br/><ce:hsp sp="1"/>ACTH (corticotropin)<ce:br/><ce:hsp sp="1"/>EPO<ce:br/><ce:hsp sp="1"/>HCG<ce:br/><ce:hsp sp="1"/>hGH</entry></row><row valign="top"><entry>Stimulants<ce:br/><ce:hsp sp="1"/>Amphetamines<ce:br/><ce:hsp sp="1"/>Ephedrine</entry></row><row valign="top"><entry>Others<ce:br/><ce:hsp sp="1"/>Local anesthetics<ce:br/><ce:hsp sp="1"/>Corticosteroids<ce:br/><ce:hsp sp="1"/>Alcohol<ce:br/><ce:hsp sp="1"/>Illicit drugs, including marijuana</entry></row></tbody></tgroup></ce:table></ce:floats><head><ce:title>Sports Doping in the Adolescent: The Faustian Conundrum of Hors De Combat</ce:title><ce:author-group><ce:author id="au1"><ce:given-name>Donald E.</ce:given-name><ce:surname>Greydanus</ce:surname><ce:degrees>MD, FAAP, FSAM, FIAP (H)</ce:degrees><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2"><ce:sup>b</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1"><ce:sup>&lowast;</ce:sup></ce:cross-ref><ce:e-address type="email">Greydanus@kcms.msu.edu</ce:e-address></ce:author><ce:author id="au2"><ce:given-name>Dilip R.</ce:given-name><ce:surname>Patel</ce:surname><ce:degrees>MD, FAAP, FACSM, FAACPDM, FSAM</ce:degrees><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff1"><ce:label>a</ce:label><ce:textfn>Department of Pediatrics &amp; Human Development, Michigan State University College of Human Medicine, 1000 Oakland Drive, Kalamazoo, MI 49008-1284, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>b</ce:label><ce:textfn>Pediatrics Program, Kalamazoo Center for Medical Studies, Michigan State University/Kalamazoo Center for Medical Studies, 1000 Oakland Drive, Kalamazoo, MI 49008-1284, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>&lowast;</ce:label><ce:text>Corresponding author. Pediatrics Program, Kalamazoo Center for Medical Studies, Michigan State University/Kalamazoo Center for Medical Studies, 1000 Oakland Drive, Kalamazoo, MI 49008-1284.</ce:text></ce:correspondence></ce:author-group><ce:abstract class="teaser"><ce:abstract-sec><ce:simple-para view="extended">The drive toward success in sports and the need for a cosmetically acceptable appearance have driven many adolescents to take a wide variety of so-called doping substances. The consumption of these chemicals in the hope and hype of improved sports performance, fueled by the easing of government restrictions on their proof of safety and efficacy, has resulted in an explosion of so-called ergogenic products available to our youth. Agents that have been used include anabolic steroids, anabolic-like agents, designer steroids, creatine, protein and amino acid supplements, minerals, antioxidants, stimulants, blood doping, erythropoietin, &beta;-blockers, and others. The use of these agents has considerable potential to cause physical and psychological damage. Use and misuse of drugs in this sports doping process should be discouraged. This discussion reviews some of the agents that are currently being used. Clinicians providing sports medicine care to youth, whether through anticipatory guidance or direct sports medicine management, should educate their young patients about the hype and hyperbole of these products that may keep them out instead of in the game at considerable financial cost to the unwary consumer.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords xml:lang="en"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Sports doping in adolescents</ce:text></ce:keyword><ce:keyword><ce:text>Anabolic-androgenic steroids</ce:text></ce:keyword><ce:keyword><ce:text>Adverse effects of anabolic steroids</ce:text></ce:keyword><ce:keyword><ce:text>Prevention of doping</ce:text></ce:keyword></ce:keywords></head><body><ce:sections><ce:para><ce:displayed-quote><ce:simple-para>&ldquo;He (it) cures most successfully in whom the people have the greatest confidence.&rdquo;</ce:simple-para></ce:displayed-quote></ce:para><ce:para>(<ce:italic>Galen, 180 <ce:small-caps>ad</ce:small-caps></ce:italic>)</ce:para><ce:para>For thousands of years, humans have sought the use of medicines, herbs, and other chemicals to improve their lives in various ways. Some scholars have interpreted the story of Adam and Eve in Genesis (chapter 3) as a story of the original humans seeking to be strong (wise) like God.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> Extensive pharmacopoeias have been developed in China and India over the past eons.<ce:cross-ref refid="bib2"><ce:sup>2</ce:sup></ce:cross-ref> The first classifier of medicinal herbs is noted by historians as the Chinese emperor Shen-Nung 2737 <ce:small-caps>bc</ce:small-caps>, and there is a classic recorded painting of him holding <ce:italic>Ephedra</ce:italic> (machuang) leaves.<ce:cross-ref refid="bib3"><ce:sup>3</ce:sup></ce:cross-ref> An early historical record of medical treatments is the <ce:italic>Ebers Papyrus</ce:italic> (1500 <ce:small-caps>bc</ce:small-caps>), which lists more than 700 medicines of various origins (mineral, vegetable, and animal).<ce:cross-refs refid="bib2 bib4"><ce:sup>2,4</ce:sup></ce:cross-refs></ce:para><ce:para>In recorded history, competitive athletes have used various mixtures of animal and plant origins, taken from known and unknown products, in attempts to improve their athletic performance and gain the perceived benefits of victory.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref> For example, athletes during the Greek and Roman Games used wines, mushrooms, and opioids; stimulants (ie, strychnine) were popular at the beginning of the twentieth century. Galen, the famous Greek who became the physician to the gladiators of ancient Rome, observed the belief of athletes of his time (180 <ce:small-caps>ad</ce:small-caps>) that consuming mushrooms and herbal teas was beneficial to their overall performance.<ce:cross-ref refid="bib3"><ce:sup>3</ce:sup></ce:cross-ref> In 1886, a cyclist died during a race in France because of a stimulant overdose.<ce:cross-ref refid="bib3"><ce:sup>3</ce:sup></ce:cross-ref> Such sports doping practices have continued in advocates of sport and others to the present age, even though such practices have been banned by sports officials. For example, the death of a British athlete at the Tour de France in 1967 was attributed to the use of amphetamines complicated by a state of dehydration, and 9 riders were ruled ineligible for the Tour de France in 2006 because of suspected sports doping.<ce:cross-ref refid="bib6"><ce:sup>6</ce:sup></ce:cross-ref></ce:para><ce:para>Athletes of old and of today have been willing to take various chemicals even without any proof of their benefit, in hope of improving their general health or their sports performance.<ce:cross-ref refid="bib7"><ce:sup>7</ce:sup></ce:cross-ref> Over thousands of years, athletes have consulted experts from the ancient days of sorcery and alchemy to modern-day biochemistry and pharmacology to find effective yet safe performance-enhancing drugs.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref> The milieu of &ldquo;victory at any cost&rdquo; that existed millennia ago continues to the present. In 1982, Goldman and colleagues<ce:cross-refs refid="bib8 bib9"><ce:sup>8,9</ce:sup></ce:cross-refs> asked 198 world-class athletes if they would take a chemical that would guarantee them success but would lead to their death in 5 years; in this survey, 52% reported they would take this chemical and this report remained at this&nbsp;level in repeat surveys between 1982 and 1995. Connor and Mazanov<ce:cross-ref refid="bib9"><ce:sup>9</ce:sup></ce:cross-ref> posed this Faustian bargain to members of the general public in Australia; they noted that only 2 of the 250 individuals surveyed agreed to take such a chemical. These sagacious members of the general public were not obsessed with victory at any cost.</ce:para><ce:para>As we enter a new millennium and century, it is sobering to realize that only a handful of the thousands of available herbal remedies of old or of modern chemistry have been shown to actually work as prescribed to better one&apos;s health.<ce:cross-refs refid="bib2 bib4 bib10"><ce:sup>2,4,10</ce:sup></ce:cross-refs> Proof of improving sports performance with various chemicals (including herbs) is even more limited. Yet, today&apos;s athletes are taking various products in ever-increasing numbers because they are driven to succeed to obtain the perceived glories of winning in contemporary society.</ce:para><ce:para>Agents that have been used in the hope of winning the game of sports and the game of life include anabolic steroids, anabolic-like agents, designer steroids, creatine, protein and amino acid supplements, minerals, antioxidants, stimulants, blood doping, erythropoietin, &beta;-blockers, sodium bicarbonate and others <ce:cross-ref refid="tbl1">Tables 1</ce:cross-ref> and&nbsp;<ce:cross-ref refid="tbl2">2</ce:cross-ref><ce:float-anchor refid="tbl1"/><ce:float-anchor refid="tbl2"/>.<ce:cross-refs refid="bib11 bib12 bib13 bib14 bib15 bib16 bib17 bib18 bib19 bib20 bib21"><ce:sup>11&ndash;21</ce:sup></ce:cross-refs> For example, a survey of 13,914 college athletes published in 1997 noted a significant intake of creatine (13%), amino acids (8%) and dehydroepiandrosterone (DHEA) (1%).<ce:cross-ref refid="bib19"><ce:sup>19</ce:sup></ce:cross-ref> Supplement use in athletes ranges between 40% and 60%.<ce:cross-refs refid="bib20 bib21"><ce:sup>20,21</ce:sup></ce:cross-refs> The teenage athlete should be carefully counseled that there are few substances (if any) that consistently and safely improve the performance of a well-trained individual. Also, the use of these agents has considerable potential to cause physical and psychological damage. Misuse of drugs in this manner (or the sports doping phenomenon as it is called) should be discouraged. This discussion reviews some of these agents that are used. Our sports youth live in a modern-day Faustian dilemma often with the encouragement of coaches, trainers, parents, the media, and other members of society obsessed with success at any price.</ce:para><ce:section id="sec2"><ce:section-title>Protection for consumers</ce:section-title><ce:para>Some progress was made in the twentieth century to help consumers understand whether or not the medications or chemical agents they take are beneficial and safe. In 1906, the Pure Food and Drug Act required foods and drugs, which were sent between various states, to be provided with accurate labels. It was not required that medications be tested for safety until the 1938 Federal Food, Drug and Cosmetic Act (FFDCA). It was also not required that these drugs be proven effective for their intended use until the 1962 Harris-Kefauver Amendment of the FFDCA. However, the 1994 Dietary Supplement Health and Education Act (DSHEA) reversed some of these gains acquired over the previous 88 years. DSHEA allowed products classified as dietary supplements to avoid the scrutiny applied to drugs or medications. Thus, manufacturers of dietary supplements (defined as a vitamin, mineral, herb, other botanic, amino acid, metabolites of these products, related metabolites, related concentrations, or extracts or combinations) do not need to prove safety or efficacy of their products. All that is needed is to note that their products &ldquo;maintain health or normal structure and function.&rdquo;<ce:cross-ref refid="bib10"><ce:sup>10</ce:sup></ce:cross-ref></ce:para><ce:para>This has opened up the commercial floodgates to various agents used by athletes in the hope that the products they use are ergogenic (see <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>).<ce:cross-refs refid="bib22 bib23 bib24"><ce:sup>22&ndash;24</ce:sup></ce:cross-refs> It is important for physicians and medical educators to be aware of these various products and to be willing to provide education to society and their patients about what is known and not known about these products.<ce:cross-ref refid="bib25"><ce:sup>25</ce:sup></ce:cross-ref> With the legal floodgates open and the continuing drive for success in sports at any cost that permeates society in the United States and the world, Americans spent more than US$12 billion on dietary supplements in 1999.<ce:cross-refs refid="bib18 bib26"><ce:sup>18,26</ce:sup></ce:cross-refs></ce:para><ce:para>Research on these products remains limited and athletes rely on word of mouth from fellow sports enthusiasts, coaches, nutrition store personnel, advertisements, and other unscientific sources for information on what drugs, herbs, or other available agents will help them improve their athletic performance or their lives in general.<ce:cross-ref refid="bib24"><ce:sup>24</ce:sup></ce:cross-ref> Most research has been done on adult men, who are involved in competitive athletics and not on teenage athletes. The potency and purity of nutritional agents are not known and the long-term effects of these various substances are also unknown at present. However, the use of ergogenic agents remains popular, and more than 30,000 individual commercial products are available throughout the world.<ce:cross-refs refid="bib20 bib27 bib28"><ce:sup>20,27,28</ce:sup></ce:cross-refs> Unproven claims (see <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>) remain while the hope of victory burns strong in athletes of all ages whether competing at the high school (or below) level or at the Olympic level of competition.<ce:cross-refs refid="bib29 bib30"><ce:sup>29,30</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec3"><ce:section-title>Definitions</ce:section-title><ce:para>The term doping is derived from the Dutch word &ldquo;dop&rdquo; in reference to the practice of providing race horses with an opium mixture to act as a stimulant and enhance victory of the competing animal.<ce:cross-ref refid="bib17"><ce:sup>17</ce:sup></ce:cross-ref> Sports doping refers to the attempt of improvement or stimulation of sports performance in <ce:italic>Homo sapiens</ce:italic> in the eternal quest for victory at any cost. The promise of having a drug that is a true sports doping chemical often belies an eternal quest for the product having an ergogenic quality, and this term is derived from the Greek words &eacute;rgon (to work) and gennan (to produce).</ce:para></ce:section><ce:section id="sec4"><ce:section-title>Anabolic steroids</ce:section-title><ce:para>Anabolic steroids or anabolic-androgenic steroids (AAS<ce:italic>)</ce:italic> are a class of chemicals that are synthetic derivatives of testosterone and represent a drug class often abused by adolescent and adult athletes.<ce:cross-ref refid="bib31"><ce:sup>31</ce:sup></ce:cross-ref> The roots of their use can be traced over 6 millennia ago when ancient farmers noted the quieting or passive effects that castration had on animals.<ce:cross-ref refid="bib32"><ce:sup>32</ce:sup></ce:cross-ref> Testosterone was isolated in 1935 and developed to improve metabolism; it was used by athletes to gain strength as early as the 1940s. Concern over the use of anabolic steroids by athletes led to an inaugural definition of sports doping by the International Olympic Committee (IOC) in 1964, the banning of these drugs by the IOC, the start of antidoping programs by the IOC in 1967, and the first official testing for these chemicals at the 1976 Montreal Olympic Games.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref></ce:para><ce:para>The term anabolic refers to the stimulation of protein synthesis, whereas androgenic implies the stimulation of male secondary sex characteristics. The terms steroids or steroid hormones refer to chemicals that are derived from cholesterol and include corticosteroids and sex hormones (ie, testosterone, estrogen, and progesterone). Anabolic steroids stimulate several receptors: androgen, estrogen, progestin, and glucocorticoid. Some examples of oral and injectable anabolic steroids are listed in <ce:cross-ref refid="tbl3">Table 3</ce:cross-ref><ce:float-anchor refid="tbl3"/>. The US Food and Drug Administration (FDA) has classified these chemicals as Schedule II drugs since 1990. Dianabol has been discontinued because of the high level of abuse noted by athletes. Adequate training and protein intake are necessary for maximal effect on protein synthesis in muscle tissue and the individual response is variable. Anabolic steroids have become the sine qua non of the Faustian bargain awaiting our youth.</ce:para><ce:section id="sec4.1"><ce:section-title>Epidemiology</ce:section-title><ce:para>It is clear that many youth try anabolic steroids including one-third who are not athletes.<ce:cross-refs refid="bib31 bib32 bib33 bib34 bib35"><ce:sup>31&ndash;35</ce:sup></ce:cross-refs> Various studies over the past few decades confirm that 5% to 11% of high school boys and 0.5 to 2.5% of high school girls in the United States have tried anabolic steroids; of these, 50% used these chemicals before 16 years of age and 33% of these youth were not athletes.<ce:cross-refs refid="bib31 bib33 bib36 bib37 bib38 bib39 bib40 bib41 bib42 bib43 bib44 bib45 bib46 bib47 bib48 bib49"><ce:sup>31,33,36&ndash;49</ce:sup></ce:cross-refs> Approximately 80% of male bodybuilders and 40% of female body builders use these drugs in contrast to 20% of college athletes; 38% of users try the injectable forms. The mean start age is about 14 years with a range of 8 to 17 years. One study looked at 1881 high school students in Georgia and noted that 5.3% of ninth grade boys and 1.5% of ninth grade girls claimed they use or had used anabolic steroids.<ce:cross-ref refid="bib50"><ce:sup>50</ce:sup></ce:cross-ref> A 1988 study of 3403 high school seniors nationally indicated that 6.6% responded they were or had used these chemicals; 38.3% were less than 16 years of age; of these, 47.1% indicated that the main reason for using these drugs was to improve their sports performance.<ce:cross-ref refid="bib36"><ce:sup>36</ce:sup></ce:cross-ref> The 2008 Monitor the Future Study noted the annual prevalence rates had dropped; for boys in the 8th, 10th, and 12th grades, it was 1.2%,1.9%, and 2.7%, respectively versus 0.6%, 0.5%, and 0.7% for girls.<ce:cross-ref refid="bib51"><ce:sup>51</ce:sup></ce:cross-ref> Several decades of research suggests a lifetime prevalence of 4% to 6% with teenage boys and 1.5% to 3% for teenage girls.<ce:cross-ref refid="bib52"><ce:sup>52</ce:sup></ce:cross-ref></ce:para><ce:para>These youth have limited knowledge of the dangers of these drugs.<ce:cross-refs refid="bib41 bib53"><ce:sup>41,53</ce:sup></ce:cross-refs> Abuse of these chemicals may be increased in the nonathletic population versus the athletic adolescent population.<ce:cross-ref refid="bib52"><ce:sup>52</ce:sup></ce:cross-ref> Adolescents who take anabolic steroids may also be involved in other high-risk behaviors, including illicit drug use such as cocaine, alcohol, cigarettes, marijuana, smokeless tobacco, and various injectable drugs.<ce:cross-refs refid="bib43 bib47 bib48 bib49 bib50 bib51 bib52 bib53 bib54 bib55"><ce:sup>43,47&ndash;55</ce:sup></ce:cross-refs> Adolescents obtain these drugs from many sources, even from veterinary suppliers. Unless they have been banned (as in Olympic competition) and drug testing is in force, anabolic steroids are popular with all athletes. Although abuse of anabolic steroids by American professional athletes has decreased somewhat in recent years, the use of these and other drugs by famous athletes has long encouraged teenagers to try these substances.<ce:cross-refs refid="bib56 bib57 bib58"><ce:sup>56&ndash;58</ce:sup></ce:cross-refs> Youth often believe that these chemicals are natural hormones and are endorsed by their sports heros.<ce:cross-ref refid="bib54"><ce:sup>54</ce:sup></ce:cross-ref> Many teenagers are convinced that these drugs are valuable and worth any risk, even in very high doses.</ce:para><ce:para>Oral anabolic steroids are 17&alpha;-alkylation chemicals that slow liver inactivation and cause much of the liver side effects of these drugs. The injectable forms are from 19&beta;-esterification processes and pose infectious disease risks, including hepatitis (B and C) and human immunodeficiency virus (HIV)/AIDS. The therapeutic doses of such drugs as used for treatment of various medical disorders are 8 to 30 mg depending on the particular drug being used. Because teenage athletes are often not afraid (nor informed) of risks, they may use prolonged and heavy (supraphysiologic) doses. They may use these drugs in various combinations in a method called stacking, that is, cycles of 6 to 12 weeks on and then off.<ce:cross-refs refid="bib47 bib53 bib59"><ce:sup>47,53,59</ce:sup></ce:cross-refs> In 1 study, 18.2% used only 1 cycle, whereas 38.1% used oral and injectable anabolic steroids.<ce:cross-ref refid="bib60"><ce:sup>60</ce:sup></ce:cross-ref> Increasing a drug dose in a cycle is called pyramiding, and doses may be 10 to more than 40 times the usual therapeutic doses.<ce:cross-ref refid="bib59"><ce:sup>59</ce:sup></ce:cross-ref> While taking several drugs together (ie, stacking), some athletes use up to 200 mg per day. These athletes may not have any fear of side effects in their quest for ergogenic qualities or even in attempts to simply improve appearance.</ce:para></ce:section><ce:section id="sec4.2"><ce:section-title>Effects</ce:section-title><ce:para>Athletes use anabolic steroids in the hope of increasing lean body mass, strength, and/or aggressiveness; as noted, some only wish to improve appearance.<ce:cross-refs refid="bib33 bib61"><ce:sup>33,61</ce:sup></ce:cross-refs> Athletes at particular risk for the use of anabolic steroids include those engaged in sports such as weight lifting, shot putting, discus throwing, bodybuilding, sprinting, football, and wrestling. If athletes take high doses of anabolic steroids while undergoing heavy resistance training, there may be an increase in body weight (with increased water retention) and lean muscle mass. One controlled study looked at adult men taking 600 mg of intramuscular testosterone and noted that they gained significant size and strength.<ce:cross-ref refid="bib62"><ce:sup>62</ce:sup></ce:cross-ref> However, not all studies agree and the exact effects of anabolic steroids are complex and not fully defined. The effect of training is important because healthy volunteers who take these drugs without training show no increase in muscle strength or muscle size. Some experiments have noted that inexperienced weight lifters who take anabolic steroids may experience an increase in body weight but not strength. Whether or not athletes get a significant increase in athletic performance remains controversial, and individualized results are the norm.</ce:para></ce:section><ce:section id="sec4.3"><ce:section-title>Adverse Effects</ce:section-title><ce:para>Side effects of anabolic steroids are legion and reviewed in <ce:cross-ref refid="tbl4">Table 4</ce:cross-ref><ce:float-anchor refid="tbl4"/>.<ce:cross-refs refid="bib33 bib45 bib46 bib63"><ce:sup>33,45,46,63</ce:sup></ce:cross-refs> Addiction to anabolic steroids may occur.<ce:cross-refs refid="bib38 bib44 bib48 bib56 bib57 bib58 bib59 bib60 bib61 bib62 bib63 bib64 bib65 bib66 bib67"><ce:sup>38,44,48,56&ndash;67</ce:sup></ce:cross-refs> One study of 164 steroid users identified 28% as being dependent on these drugs.<ce:cross-ref refid="bib68"><ce:sup>68</ce:sup></ce:cross-ref>The maturation process may be accelerated in growing athletes with possible early closure of epiphyses and shortened ultimate adult height. An increase in tendon injuries has also been reported in teenagers on anabolic steroids. Liver complications are many and are related to the oral alkylated forms; these adverse effects include increase in liver function tests, peliosis hepatitis, cholestasis, hepatic failure, and hepatic neoplasms (benign and malignant). Risks for cardiovascular disorders occur, including hypertension, reports of cardiomyopathy, and various thrombogenic phenomena such as myocardial infarctions, cerebrovascular accidents, and sudden death.<ce:cross-refs refid="bib69 bib70 bib71 bib72 bib73"><ce:sup>69&ndash;73</ce:sup></ce:cross-refs></ce:para><ce:para>Masculinization of females may occur with changes such as hirsutism and clitoromegaly, both of which may be permanent; deepening of the voice is an irreversible effect of anabolic steroids in females. Amenorrhea, male-pattern baldness, and skin coarseness may also be seen in women; the skin changes may be permanent. Female athletes try to get a high enough dose to get the expected or desired results on muscle mass, but low enough to prevent unwanted side effects such as masculinization. Hair loss and severe acne may be seen in both sexes. Males may develop gynecomastia (partly irreversible) and prostatic enlargement (with possible increased risk for prostatic cancer). The reduction in testicular size is reversible, but abnormalities of germinal elements can persist for several weeks after cessation of anabolic steroids.</ce:para></ce:section><ce:section id="sec4.4"><ce:section-title>Use of Additional or Concomitant Doping Agents</ce:section-title><ce:para>Users of AAS may use other drugs as well.<ce:cross-ref refid="bib48"><ce:sup>48</ce:sup></ce:cross-ref> For example, they may use human growth hormone (hGH), methamphenamine, or clenbuterol (see later discussion) to augment the anabolic effects of AAS. Human chorionic gonadotropin (HCG) may be added to raise testosterone synthesis and counter the anabolic steroid-induced effect of testicular atrophy. Diuretics (eg, furosemide, spironolactone, hydrochlorothiazide) may be used to reduce fluid retention, produce the desired rippled look, or dilute urine to subvert a drug-screening regimen. The use of diuretics to lose weight quickly is not an unusual plan of wrestlers. The use of such medications can result in increased weakness such that a wrestler can be injured by competing against a stronger opponent. Electrolyte dysfunction and other medical side effects of diuretics may complicate the picture. Pulmonary embolism has been reported in a high school wrestler using such a regimen.<ce:cross-ref refid="bib74"><ce:sup>74</ce:sup></ce:cross-ref></ce:para><ce:para>Stimulants may be taken along with AAS to increase the drive for exercise and competition, whereas anti-acne medications are used to deal with the anabolic steroid-induced acne. Antiestrogens (as tamoxifen or clomiphene) may be used to prevent male feminization effects (ie, gynecomastia) of anabolic steroids. These athletes may use other drugs as well in the course of their training, such as antibiotics, corticosteroids (ie, prednisone), and analgesics (eg, morphine, propoxyphene, meperidine, oxycodone, and others). Narcotics and other illicit drugs are abused for their pleasure-granting effects as well. Corticotrophin (ACTH) is used to raise levels of internally produced corticosteroids and to produce a sense of euphoria.</ce:para></ce:section><ce:section id="sec4.5"><ce:section-title>Prevention</ce:section-title><ce:para>The use of anabolic steroids poses significant risks to the user/abuser and these chemicals have been banned by the (IOC), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other sporting associations. However, it is often difficult for the adolescent user to stop because many young people have difficulty understanding the consequences of their actions (concrete thinking) and have difficulty avoiding the win-at-all-cost attitude prevalent in the global sports milieu.<ce:cross-refs refid="bib29 bib30 bib41 bib56 bib57 bib75 bib76"><ce:sup>29,30,41,56,57,75,76</ce:sup></ce:cross-refs> It is important to educate youth about these sports doping agents.<ce:cross-ref refid="bib59"><ce:sup>59</ce:sup></ce:cross-ref> Parents and coaches must be taught about these chemicals and they should not encourage the use of such potentially dangerous chemicals under the guise of &ldquo;Winning is Everything!&rdquo; Goldberg and colleagues<ce:cross-refs refid="bib77 bib78"><ce:sup>77,78</ce:sup></ce:cross-refs> have introduced the ATLAS model or the Adolescent Training and Learning to Avoid Steroids Program with some success.</ce:para><ce:para>Although there may be some medical indications for these drugs (ie, treatment of HIV-associated wasting or chronic renal failure), seeking to improve sports performance should not be one of the medical indications to use these drugs.<ce:cross-refs refid="bib11 bib44 bib79"><ce:sup>11,44,79</ce:sup></ce:cross-refs> Guidelines for following athletes who insist on taking anabolic steroids are provided by Blue and Lombardo.<ce:cross-ref refid="bib64"><ce:sup>64</ce:sup></ce:cross-ref> The effort to ban anabolic steroids has now been complicated with the appearance of designer steroids, the first of which was norbolethone that was initially detected by a laboratory in Los Angeles in 2002.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref> Other identified designer steroids include madol (desoxy-methyl testosterone) and tetrahydrogestrinone. Unfortunately, experts and amateurs in the biochemistry industry continue to produce such drugs, and the cat and mouse game between sports dopers and sports officials will continue in perpetuum.</ce:para></ce:section><ce:section id="sec4.6"><ce:section-title>Other Anabolic-like Agents</ce:section-title><ce:section id="sec4.6.1"><ce:section-title>DHEA</ce:section-title><ce:para>DHEA is a mildly androgenic hormone naturally produced in the adrenal glands and testes. It is the precursor to testosterone (as well as dihydrotestosterone) and estrogen. Although DHEA is banned by the FDA and has no proven ergogenic effects, it is used by athletic teens and adults as an alternative to anabolic steroids.<ce:cross-refs refid="bib31 bib48 bib80"><ce:sup>31,48,80</ce:sup></ce:cross-refs> The ergogenic attempt is based on a hope and hype that DHEA will increase testosterone and an anabolic insulin-like growth factor (IGF-I). Despite animal studies having shown some DHEA-induced liver toxicity, it is marketed to adults (middle-aged and older) as an over-the-counter alternative to anabolic steroids with additional unproven claims of promoting euphoria, enhancing libido, delaying cardiovascular disease, preventing cancer, and boosting one&apos;s immunity.<ce:cross-ref refid="bib17"><ce:sup>17</ce:sup></ce:cross-ref> Research is limited on DHEA.<ce:cross-ref refid="bib65"><ce:sup>65</ce:sup></ce:cross-ref> One study evaluated men (average age 24 years) who used 1600 mg per day for 4 weeks; serum testosterone levels were not altered.<ce:cross-ref refid="bib81"><ce:sup>81</ce:sup></ce:cross-ref> Another study called the Andro Project also noted no ergogenic qualities of DHEA.<ce:cross-ref refid="bib82"><ce:sup>82</ce:sup></ce:cross-ref></ce:para><ce:para>DHEA is given at a dose of 50 to 100 mg per day for 6 to 12 months in oral or injectable forms, up to 1600 mg. Side effects may occur as with ingestion of sex hormones. At doses of more than 100 mg/day, gynecomastia (irreversible) in men and hirsutism in women can occur; cancer (prostate or endometrial) may be worsened.<ce:cross-ref refid="bib83"><ce:sup>83</ce:sup></ce:cross-ref> DHEA should be considered as an anabolic steroid and teenagers should be advised not to use it. The FDA has ruled it has no medical usage, and it has been banned by the National Hockey League, the IOC, the NFL, among others (<ce:cross-ref refid="tbl5">Tables 5</ce:cross-ref><ce:float-anchor refid="tbl5"/> and <ce:cross-ref refid="tbl6">6</ce:cross-ref><ce:float-anchor refid="tbl6"/>).</ce:para></ce:section><ce:section id="sec4.6.2"><ce:section-title>Androstenedione</ce:section-title><ce:para>Androstenedione is another androgen produced by the adrenal gland and testes; it is a precursor of estrogen and testosterone (as well as dihydrotestosterone) and is found in Scotch pine tree pollen.<ce:cross-refs refid="bib84 bib85 bib86"><ce:sup>84&ndash;86</ce:sup></ce:cross-refs> Androstenedione is available in Europe as a nasal spray and is used in the United States in a pill form. It is used as a T-booster in hope of increasing testosterone; serum testosterone/estrogen ratios are normalized within 1 day of stopping this drug. High doses (as 100&ndash;300 mg per day and 60 minutes before an event) may increase lean muscle mass and strength. Studies note that 300 mg of androstenedione increases testosterone, estrone, and estradiol levels more than 100 mg.<ce:cross-ref refid="bib26"><ce:sup>26</ce:sup></ce:cross-ref> It is often used in combination with different anabolic steroids in various cycling methods.<ce:cross-ref refid="bib80"><ce:sup>80</ce:sup></ce:cross-ref></ce:para><ce:para>Androstenedione is a banned chemical with unknown long-term safety. Side effects are the same as noted with anabolic steroids; the potency and safety of available products are unknown. It should be avoided with growing athletes and for those at risk for prostate or breast cancer. Androstenedione and other steroidal supplements may be packaged with various other chemicals, such as ephedrine, caffeine, saw palmetto, and others.<ce:cross-ref refid="bib65"><ce:sup>65</ce:sup></ce:cross-ref> Although banned by the IOC, NFL and NCAA, androstendione remains a popular sports doping agent (see <ce:cross-ref refid="tbl5">Tables 5</ce:cross-ref> and <ce:cross-ref refid="tbl6">6</ce:cross-ref>).</ce:para></ce:section><ce:section id="sec4.6.3"><ce:section-title>Human growth hormone (hGH)</ce:section-title><ce:para>hGH has been used especially by power and speed athletes in attempts to increase lean muscle mass and strength, often in combination with anabolic steroids.<ce:cross-refs refid="bib11 bib31"><ce:sup>11,31</ce:sup></ce:cross-refs> However, ergogenic effects have not been proven, even when using supraphysiologic doses.<ce:cross-ref refid="bib87"><ce:sup>87</ce:sup></ce:cross-ref> Although tests are available, it is difficult to detect all users and the user runs the risk of having an impure product obtained illegally.<ce:cross-refs refid="bib88 bib89"><ce:sup>88,89</ce:sup></ce:cross-refs> Recombinant DNA technology has provided recombinant hGH (rhGH) to those able to pay the high cost of this agent (more than US$3000 per month).<ce:cross-ref refid="bib89"><ce:sup>89</ce:sup></ce:cross-ref> A survey of more than 200 high school male athletes noted that 5% were on hGH.<ce:cross-ref refid="bib48"><ce:sup>48</ce:sup></ce:cross-ref> The question of hGH purity as a natural product was previously raised with the development of Creutzfeld-Jacobs disease. Side effects of hGH supplementation may include jaw enlargement, gigantism, hypertension, hyperglycemia, fluid retention, carpal tunnel syndrome, slipped capital femoral epiphysis, and pseudotumor cerebri.<ce:cross-refs refid="bib18 bib89"><ce:sup>18,89</ce:sup></ce:cross-refs> Although several amino acids (arginine, ornithine, lysine, and tryptophan) are used to induce release of hGh, doses usually used do not significantly raise hGH in the body.</ce:para></ce:section><ce:section id="sec4.6.4"><ce:section-title>&gamma;-Hydroxybutyrate</ce:section-title><ce:para>&gamma;-Hydroxybutyrate (GHB, Liquid Ecstasy, G, Georgia home boy) is a central nervous system depressant that leads to euphoria and lowering of inhibition.<ce:cross-refs refid="bib90 bib91"><ce:sup>90,91</ce:sup></ce:cross-refs> GHB is popular with body builders with the hype and hope of increasing growth hormone release during sleep and enhancing muscle growth. GHB can be made at home with recipes found on the Internet and with ingredients easily purchased. It is made as a clear liquid or white powder; tablets or capsules are available. It is also used as a date-rape pill to enhance sexual assault; as a colorless, odorless and tasteless liquid, it is easily slipped into party drinks to produce sedation and amnesia; effects are noted in 10 to 20 minutes and last for 4 hours. It is quickly cleared from the body and is hard to detect. Thus, it has become a popular date-rape drug. An overdose can lead to profound respiratory depression, coma, and death.</ce:para><ce:para>Because the United States government is cracking down on GHB use, some are taking GHB metabolites or precursors, such as &gamma;-butyrolactone (GBL) and even the industrial solvent, 1,4-butanediol (BD). After ingestion of GBH, it becomes GHB. Some companies are substituting BD for GHB, even though BD has been declared a potentially life-threatening drug by the FDA. It is marketed as a dietary supplement in various sleep aid and muscle builder products. Although it is promoted to enhance sexual performance, BD slows breathing and can lead to unconsciousness, emesis, seizures, and death.</ce:para></ce:section><ce:section id="sec4.6.5"><ce:section-title>Clenbuterol</ce:section-title><ce:para>Clenbuterol (Clensasma; Broncoterol) is a &beta;2 agonist bronchodilator (substituted phenylethanolamine) that is used with anabolic steroids in attempts to improve lean body mass and decrease adipose tissue.<ce:cross-refs refid="bib11 bib44 bib54 bib92 bib93 bib94"><ce:sup>11,44,54,92&ndash;94</ce:sup></ce:cross-refs> It is available in Europe, Central America, and South America. Clenbuterol can be given orally with full absorption, whereas aerosol and injection forms are also available. If used therapeutically for asthma, the dose is 0.02 to 0.04 mg per day; if used ergogenically, a dose of 0.02 to 0.16 mg per day is tried. Clenbuterol can be used in a 2-day on and 2-day off cycle for several weeks and then stopped before the athletic event, because it can be detected for 2 to 4 days after the last dose.</ce:para><ce:para>However, it is not proven that it increases muscle mass and reduces adipose tissue, certainly not to the extent attributed to anabolic steroids. Several side effects are observed, including tachycardia, headaches, anxiety, dizziness, nausea, tremor, and insomnia. Concern is raised that it may lead to arrhythmias, myocardial infarction, cardiac muscle hypertrophy, and cerebrovascular accidents. It is banned by many sport agencies, including the IOC, United States Olympic Committee, NCAA, and others (see <ce:cross-ref refid="tbl5">Tables 5</ce:cross-ref> and <ce:cross-ref refid="tbl6">6</ce:cross-ref>).</ce:para><ce:para>To avoid sanctions for using a medication (even with a prescription) at Olympic competition levels, rules of the World Anti-Doping Code must be followed in which the International Standard for Therapeutic Use Exemptions are used.<ce:cross-ref refid="bib95"><ce:sup>95</ce:sup></ce:cross-ref> Sports doping has been viewed by authorities as being an unfair and unethical advantage in sports competition. The IOC developed a medical commission in 1967 and they have produced a list of substances that are prohibited for athletes to use as well as various antidoping regulations.<ce:cross-ref refid="bib96"><ce:sup>96</ce:sup></ce:cross-ref> Specific screening for prohibited drugs was initiated at the 1972 Munich Olympic Games. In 1999, the World Anti-Doping Agency (WADA) was developed and this agency organized a worldwide effort to standardize and enforce antidoping regulations.<ce:cross-ref refid="bib31"><ce:sup>31</ce:sup></ce:cross-ref> WADA has published the 2009 World Anti-Doping Code listing categories of banned substances and methods used for doping; they provide a list of substances banned in competition and in specific sports (see <ce:cross-ref refid="tbl5">Table 5</ce:cross-ref>).<ce:cross-ref refid="bib31"><ce:sup>31</ce:sup></ce:cross-ref> Athletes must be careful even with prescription drugs that are prescribed for them or misuse of medications that are being prescribed for someone else.<ce:cross-ref refid="bib97"><ce:sup>97</ce:sup></ce:cross-ref></ce:para></ce:section><ce:section id="sec4.6.6"><ce:section-title>Others</ce:section-title><ce:para>IGF-I is a single-chain 70 amino acid polypeptide that contributes to the growth-enhancing effects of hGH.<ce:cross-ref refid="bib48"><ce:sup>48</ce:sup></ce:cross-ref> Provision of injectable r-IGF-I produces similar effects to rhGH, and to the appreciation of female athletes, there is no virilization. This product&apos;s high cost (more than US$3000 per month) limits its use. Anabolic phytosteroids (plant steroids) are marketed to athletes as plant extracts that have similar effects as anabolic steroids, but without the side effects. These products include &gamma;-oryzanol, ferulic acid, &beta;-sitosterol, and Smilax.<ce:cross-ref refid="bib18"><ce:sup>18</ce:sup></ce:cross-ref> There is no evidence for their ergogenic properties and their purity as purchased is not guaranteed. Potential adverse effects include hyperglycemia, respiratory problems, increased blood pressure, cardiomyopathy, and others.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref> Insulin itself has been used in attempts to augment transport of glucose into muscle cells with potential adverse effects such as hypoglycemia, coma, and death.</ce:para></ce:section></ce:section></ce:section><ce:section id="sec5"><ce:section-title>Creatine</ce:section-title><ce:para>Creatine is an essential amino acid synthesized from arginine, glycine, and methionine, mainly in the kidneys, and to a lesser extent in the liver and pancreas. It is available in milk, meat, fish, and other foods, although meat and fish are the main food source and supply more than half of the daily requirement.<ce:cross-refs refid="bib27 bib28 bib31 bib80 bib90 bib98"><ce:sup>27,28,31,80,90,98</ce:sup></ce:cross-refs> The usual diet provides 1 to 2 g of creatine per day. It is a tasteless crystalline powder that is readily dissolved in liquids and is usually marketed as creatine monohydrate or with phosphorus.<ce:cross-ref refid="bib99"><ce:sup>99</ce:sup></ce:cross-ref> At all levels of competition (from high school to professional), creatine is the most popular nutritional supplement sold today as an ergogenic agent.<ce:cross-refs refid="bib27 bib28 bib31 bib90 bib98 bib100 bib101 bib102 bib103 bib104"><ce:sup>27,28,31,90,98,100&ndash;104</ce:sup></ce:cross-refs> In a well-known 1997 study by the NCAA in which more than 1400 college athletes were surveyed, 32% had used creatine in the 12 months before the survey.<ce:cross-ref refid="bib98"><ce:sup>98</ce:sup></ce:cross-ref> In a study of 520 British athletes, 36.1% reported use of creatine and many believed that they were able to train longer and/or maintain strength using creatine.<ce:cross-ref refid="bib104"><ce:sup>104</ce:sup></ce:cross-ref> Although annual sales of creatine are more than US$200 million, there remains little research on its effects on adolescents.<ce:cross-refs refid="bib12 bib17 bib103"><ce:sup>12,17,103</ce:sup></ce:cross-refs></ce:para><ce:para>All but 5% of creatine is stored in skeletal muscle (especially the fast twitch, type II muscle), two-thirds as a phosphorylated form, and one-third as free creatine. This substance serves as an energy substrate for the contraction of skeletal muscle in the body. Cells with high-energy requirements use creatine in the form of phosphocreatine, which functions as a donor of phosphate to produce adenosine triphosphate from adenosine diphosphate. Cells in the skeletal muscles store enough phosphocreatine and adenosine triphosphate (ATP) for about 10 seconds of high-intensity action.<ce:cross-refs refid="bib80 bib100"><ce:sup>80,100</ce:sup></ce:cross-refs> The purpose of creatine supplementation is to increase resting phosphocreatine levels in muscles and free creatine to briefly postpone fatigue, with potential ergogenic results.<ce:cross-refs refid="bib99 bib100"><ce:sup>99,100</ce:sup></ce:cross-refs> Phosphocreatine maintains high energy ATP levels, acts as a proton buffer, and can lead to reduced glycolysis. When the phosphocreatine levels decrease, glycolysis increases. Maximal exercise eventually stops because of muscle fatigue, probably because of accumulation of lactate and hydrogen ions in addition to a decrease in ATP.</ce:para><ce:para>Is creatine an ergogenic supplement? Studies in adult athletes suggest there may be a 5% to 15% improvement in short-term (&lt;30 seconds), repetitive/intermittent, high-intensity exercise.<ce:cross-refs refid="bib18 bib27 bib28 bib102 bib105 bib106 bib107"><ce:sup>18,27,28,102,105&ndash;107</ce:sup></ce:cross-refs> Some literature tends to suggest it is probably beneficial for those in power sports (ie, football, sprinters), but not for those in endurance sports (eg, swimming). However, not all the literature agrees that there is any improved sports performance.<ce:cross-refs refid="bib31 bib108 bib109 bib110 bib111 bib112"><ce:sup>31,108&ndash;112</ce:sup></ce:cross-refs> Some athletes may have a low intracellular concentration of creatine and thus may respond to it, whereas those with a higher level do not respond. Most in vivo studies show no improvement in sports performance.<ce:cross-ref refid="bib80"><ce:sup>80</ce:sup></ce:cross-ref> Also, no studies report any improvement with long-term endurance activities.</ce:para><ce:para>The work of Harris and colleagues<ce:cross-refs refid="bib113 bib114"><ce:sup>113,114</ce:sup></ce:cross-refs> has led to the current practice of many athletes using a loading dose of 20 g per day (5 g four times a day) for 5 to 7 days followed by 2 to 5 g per day for maintenance. Other loading and maintenance doses are also used. For example, research suggests an equally beneficial effect may be seen with 3 g a day versus a loading dose of 20 g a day.<ce:cross-ref refid="bib115"><ce:sup>115</ce:sup></ce:cross-ref> The loading routine may maximize the amount of phosphocreatine in muscles, whereas a maintenance dose may keep muscles filled. Positive results are best with an active exercise program, although there is no need to take creatine specifically before or during exercise. Increased muscle mass may result because of fluid (water) retention and not increased protein synthesis.<ce:cross-ref refid="bib114"><ce:sup>114</ce:sup></ce:cross-ref> An increase of 0.7 to 3 kg. in 1 month has been reported; weight gain can be maintained on 5 g per day of creatine during a 10-week period of detraining and maintained 4 weeks after its use is stopped.</ce:para><ce:para>Although creatine is generally regarded as safe, there may be side effects and risks, especially when consuming more than 20 g per day. The best-known effect is weight gain because of fluid (water) retention. Other adverse effects that are often cited but not proven include anecdotal reports of muscle cramps, strains, dehydration in hot/humid weather, renal function deterioration, suppression of endogenous synthesis, and possible cardiac muscle hypertrophy. Other anecdotal concerns include abdominal pain, dyspnea, nausea, emesis, diarrhea, anxiety, fatigue, migraine headaches, seizures, myopathy, and atrial fibrillation.<ce:cross-refs refid="bib17 bib80"><ce:sup>17,80</ce:sup></ce:cross-refs> Long-term (ie, more than 1 year) effects are unknown and no studies are reported in children or adolescents.<ce:cross-ref refid="bib20"><ce:sup>20</ce:sup></ce:cross-ref> Supplementation does reduce endogenous creatine production, with unknown results on the body. Although it is not banned by any major sports groups, the American College of Sports Medicine recommends that those less than 18 years of age should not use creatine.<ce:cross-ref refid="bib115"><ce:sup>115</ce:sup></ce:cross-ref></ce:para></ce:section><ce:section id="sec6"><ce:section-title>Stimulants</ce:section-title><ce:section id="sec6.1"><ce:section-title>Ephedrine</ce:section-title><ce:para>Ephedrine is a medication that can have beneficial effects in disease states (eg, asthma), but which is not acceptable to various sports medicine committees because of potential harmful effects.<ce:cross-refs refid="bib18 bib20 bib116 bib117"><ce:sup>18,20,116,117</ce:sup></ce:cross-refs> It is an example of using a stimulant drug to seek improvement in one&apos;s performance in training or competition. Although not proven to be ergogenic, it has been used by various athletes in this regard. Other stimulants include amphetamine and caffeine. They are used to reduce the sense of being tired, lessen the feeling of pain, and heighten aggressiveness.<ce:cross-ref refid="bib45"><ce:sup>45</ce:sup></ce:cross-ref> As noted earlier, stimulants have been used by athletes over the eons as performance-enhancing chemicals. The Incas in South America chewed coca leaves to help them run long distances.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref></ce:para><ce:para>In the case of ephedrine, many believe its sympathomimetic action gives the user an unfair advantage and is thus banned (see <ce:cross-ref refid="tbl5">Tables 5</ce:cross-ref> and <ce:cross-ref refid="tbl6">6</ce:cross-ref>). However, &beta;2 agonists such as terbutaline and salbuterol are accepted in the Olympics if the athlete has documented asthma and informs the Olympic Committee of their use. The purpose is to allow the athlete proper treatment of a verified disorder (ie, asthma), but not to allow him/her to gain an unfair advantage over the competitors (ie, using stimulants).</ce:para><ce:para>Ephedrine alkaloids are derived from ephedra herbs (also called ma huang). Athletes use dietary supplement products that contain ma huang to improve muscle tone and energy levels, although there is no proof of these claims.<ce:cross-refs refid="bib10 bib17"><ce:sup>10,17</ce:sup></ce:cross-refs> Negative effects have been identified, including more than 800 adverse reports that were investigated by the FDA between 1994 and 1997 (FDA, June 2, 1997). These incidents involved otherwise healthy young to middle-aged adults who developed various complications while on these products; these included hypertension, arrhythmias, anxiety, tremors, insomnia, seizures, paranoid psychoses, cerebrovascular accidents, myocardial infarctions, and death.<ce:cross-ref refid="bib118"><ce:sup>118</ce:sup></ce:cross-ref> The FDA recommended limiting consumers to 24 mg of ephedra alkaloids and wanted labels to limit these products to 7 days and alert the public to these potential problems if high doses were taken. No official government action in this regard has been taken and the FDA was requested to provide more data. Despite such adverse reports, more than US$1 billion was spent by consumers of ephedra products in 2000.<ce:cross-ref refid="bib10"><ce:sup>10</ce:sup></ce:cross-ref></ce:para></ce:section><ce:section id="sec6.2"><ce:section-title>Caffeine</ce:section-title><ce:para>Caffeine is a xanthine derivative that is used by many athletes.<ce:cross-refs refid="bib31 bib119"><ce:sup>31,119</ce:sup></ce:cross-refs> In a study of 520 British athletes in which 36.1% reported use of creatine, caffeine use as a sports doping agent was reported by 23.8%.<ce:cross-ref refid="bib104"><ce:sup>104</ce:sup></ce:cross-ref> It may improve performance in steady state endurance activities that rely on fat for fuel, because this chemical increases lipid metabolism. It increases the release of free fatty acids from adipocytes and stimulates catecholamine activity.<ce:cross-refs refid="bib44 bib120"><ce:sup>44,120</ce:sup></ce:cross-refs> Studies have noted that ingestion of 2 to 3 cups of coffee (100&ndash;150 mg of caffeine per cup) increases the endurance of individuals cycling to exhaustion on bicycle ergometers. Coffee seems to reduce the perception of fatigue and allow further performance. However, an excessive amount increases sympathomimetic stimulation, which can interfere with overall athletic performance. Its diuretic effect can also interfere with such performance. Excessive amounts were banned from Olympic competition and is defined as more than 12 to 15 &mu;g/mL in the urine; this usually results from ingestion of 6 to 8 cups of coffee.<ce:cross-ref refid="bib18"><ce:sup>18</ce:sup></ce:cross-ref> This ban was recently lifted. Other sources of caffeine include tea, over-the-counter pills for sleepiness, and some analgesic pills that contain caffeine.</ce:para></ce:section></ce:section><ce:section id="sec7"><ce:section-title>Blood doping and EPO</ce:section-title><ce:para>Blood doping (bloodboosting or blood packing), in which athletes receive transfusions of their own blood, is an attempt to increase aerobic performance.<ce:cross-refs refid="bib31 bib121 bib122"><ce:sup>31,121,122</ce:sup></ce:cross-refs> It is impossible to detect by laboratory tests and the frequency of use among athletes is unknown. Hemoglobin levels may reach 19 to 20 g/dL, especially during intense competition (eg, cycling competition at high altitudes), which leads to dehydration.<ce:cross-ref refid="bib44"><ce:sup>44</ce:sup></ce:cross-ref></ce:para><ce:para>EPO is a renal glycoprotein that stimulates red cell production.<ce:cross-refs refid="bib31 bib121 bib122"><ce:sup>31,121,122</ce:sup></ce:cross-refs> Recombinant EPO (rEPO) is used to increase aerobic capacity and thus has become popular with endurance athletes (eg, runners and cyclists)<ce:cross-ref refid="bib44"><ce:sup>44</ce:sup></ce:cross-ref> rEPO is difficult to detect and has a half-life of 20 hours. As noted with blood doping, several side effects are reported, including increased blood viscosity, hypertension, coronary artery occlusion, cerebrovascular accidents, seizures, and sudden death. Dehydration from intense sports activity may trigger some of these complications. It is difficult to detect; it is as effective in increasing aerobic capacity as blood doping and its use is banned.<ce:cross-refs refid="bib121 bib122"><ce:sup>121,122</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec8"><ce:section-title>Miscellaneous sports doping agents</ce:section-title><ce:para>&beta;-Blockers (ie, propranolol, clinetrol, metoprolol) have been used to reduce anxiety, lessen hand tremor, control tachycardia, and reduce hypertension. Hand control is important in sports such as archery and riflery; these athletes may also use benzodiazepines and barbiturates for relief of anxiety and insomnia.<ce:cross-ref refid="bib44"><ce:sup>44</ce:sup></ce:cross-ref> These agents, like many others, are banned from many competitive sports (see <ce:cross-ref refid="tbl5">Tables 5</ce:cross-ref> and <ce:cross-ref refid="tbl6">6</ce:cross-ref>). Potential side effects of &beta;-blockers include various well-known cardiovascular, hematologic, central nervous system, and gastrointestinal symptomatology.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref></ce:para><ce:para>Ergolytic illicit drugs include alcohol (also used in small amounts for hand control), marijuana, nicotine, cocaine, amphetamines, and others.<ce:cross-ref refid="bib55"><ce:sup>55</ce:sup></ce:cross-ref> Nicotine may improve central nervous system attention span in some, but may also worsen hand steadiness. Insulin has been misused in sports by some because of its anabolic and anticatabolic effects. Drug testing has been developed to detect this practice.<ce:cross-ref refid="bib123"><ce:sup>123</ce:sup></ce:cross-ref> Selective androgen receptor moderators are a class of drugs with the potential for use and abuse as sports doping agents and drug testing technology is being developed to detect SARMs.<ce:cross-ref refid="bib124"><ce:sup>124</ce:sup></ce:cross-ref> A selective progesterone receptor modulator is an agent that works on the progesterone receptor with an agonist action on some tissues and an antagonist action in others. Some athletes seek to use such unapproved and controversial chemicals with the eternal sports doping hope from advertised hype that improved sports performance will occur without undesirable side effects.</ce:para><ce:para>Sodium bicarbonate is an alkaline salt that has been used to delay fatigue during bouts of exercise that are limited by acidosis; this may be helpful in cases where the blood flow can increase to accommodate an increase in the by-products of increased muscles at work.<ce:cross-refs refid="bib17 bib44"><ce:sup>17,44</ce:sup></ce:cross-refs> Nonsteroidal antiinflammatory agents have been used to relieve pain and allow athletes to increase their performance despite painful injuries; this can lead to greater, more permanent injuries.<ce:cross-ref refid="bib44"><ce:sup>44</ce:sup></ce:cross-ref> Such medications have erroneously been used to quicken healing of muscle soreness after exercise. Side effects of such medications include gastrointestinal bleeding, reduced platelet aggregation, reduced renal perfusion, increased salt/water retention, and thermal regulation dysfunction with resultant heat illness. Another agent falsely used as an antiinflammatory agent by athletes is dimethyl sulfoxide (DMSO). This chemical has been available in over-the-counter preparations and is rubbed onto sore or injured areas. Its effectiveness as an antiinflammatory agent has never been proved by research and its production does not occur under standards acceptable for human use.</ce:para><ce:para>There are many other substances sold as ergogenic agents, such as ginkgo biloba, ginseng, yohimbine (yohimbe), coenzyme Q<ce:inf>10</ce:inf>, and others as listed in <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref>.<ce:cross-refs refid="bib17 bib125"><ce:sup>17,125</ce:sup></ce:cross-refs> Nutritional supplements in sports are reviewed in other articles.<ce:cross-refs refid="bib11 bib13 bib17 bib22 bib26 bib31 bib83 bib90"><ce:sup>11,13,17,22,26,31,83,90</ce:sup></ce:cross-refs> In a study of 520 British athletes in which 36.1% reported use of creatine, use of ginseng as a potential sports doping agent was reported by 8.3%.<ce:cross-ref refid="bib104"><ce:sup>104</ce:sup></ce:cross-ref> Although their value in bettering health and improving sports performance remains controversial, their use continues by a population not willing to wait for scientific studies to provide helpful guidance. The purity and safety of these products are not guaranteed but this does not prevent youth and other athletes from using them in high amounts. Clinicians providing sports medicine care to youth, whether through anticipatory guidance or direct sports medicine management, should educate their young patients about the never-ending hype and hyperbole of these ergogenic products.<ce:cross-refs refid="bib11 bib17 bib25 bib126"><ce:sup>11,17,25,126</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec9"><ce:section-title>Summary</ce:section-title><ce:para>The ancient Olympic Games took place from 776 <ce:small-caps>bc</ce:small-caps> to 393 <ce:small-caps>ad</ce:small-caps> and sports doping was quite common among athletes of ancient societies.<ce:cross-ref refid="bib5"><ce:sup>5</ce:sup></ce:cross-ref> The modern Olympic Games began in 1896 in Athens, Greece, under the influence of Baron Pierre de Coubertin who emphasized the need for sports to honor competition over winning.<ce:cross-ref refid="bib3"><ce:sup>3</ce:sup></ce:cross-ref> Unfortunately, the milieu of winning is everything persists and athletes will accept the Goldman challenge in their pursuit of performance-enhancing drugs. Most consumed agents do not improve performance, and risks of severe adverse effects continue to complicate the Faustian dilemma that athletes at all levels face in the early twenty-first century. It may have begun with an apple, but sports doping has now evolved into anabolic steroids, designer steroids, and other dangerous chemicals. Sports doping is also a part of the greater issue of illicit drug use that is so prevalent in youth and adults of the world.<ce:cross-refs refid="bib52 bib56 bib57"><ce:sup>52,56,57</ce:sup></ce:cross-refs> Our children and youth must be educated about proper exercise and nutrition. They are curious about using potential sports doping chemicals of all types.<ce:cross-ref refid="bib127"><ce:sup>127</ce:sup></ce:cross-ref> We must teach our children and adolescents that sports doping is neither a safe nor effective way to succeed in the game of life on or off the field.<ce:cross-ref refid="bib128"><ce:sup>128</ce:sup></ce:cross-ref> We need to reinstate Baron Pierre de Coubertin&apos;s view of competition over victory as the raison d&apos;&ecirc;tre for sports participation among our children and youth. Sports doping is an important cause of hors de combat in contemporary twenty first century sports society.<ce:displayed-quote><ce:simple-para>&ldquo;When there is noble competition, there is victory&rdquo;</ce:simple-para></ce:displayed-quote></ce:para><ce:para>(<ce:italic>Aristotle, 4th Century <ce:small-caps>bc</ce:small-caps></ce:italic>)</ce:para></ce:section></ce:sections></body><tail><ce:bibliography><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>1</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.Z.</ce:given-name><ce:surname>Csaky</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Doping</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Sports Med Phys Fitness</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>1972</sb:date></sb:issue><sb:pages><sb:first-page>117</sb:first-page><sb:last-page>123</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>2</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Grollman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Alternative medicine: the importance of evidence in medicine and medical evidence. Foreword: is there wheat among the chaff?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acad Med</sb:maintitle></sb:title><sb:volume-nr>76</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>221</sb:first-page><sb:last-page>223</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>3</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>E.H.</ce:given-name><ce:surname>De Rose</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Doping in athletes: an update</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>107</sb:first-page><sb:last-page>130</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>4</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Porter</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The greatest benefit to mankind: a medical history of humanity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>1998</sb:date><sb:publisher><sb:name>WW Norton &amp; Co</sb:name><sb:location>New York</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>5</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Botr&egrave;</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pavan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Enhancement drugs and the athlete</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurol Clin</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>149</sb:first-page><sb:last-page>167</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>6</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lippi</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Franchini</ce:surname></sb:author><sb:author><ce:given-name>G.C.</ce:given-name><ce:surname>Guidi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Switch off the light on cycling, switch off the light on doping</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title></sb:series><sb:date>2007</sb:date></sb:issue></sb:host><sb:comment>Available at:</sb:comment><sb:host><sb:e-host><ce:inter-ref xlink:href="http://dopingjournal.org/noteworthy/achive/2007_11_01%3Carchive.html">http://dopingjournal.org/noteworthy/achive/2007_11_01&lt;archive.html</ce:inter-ref></sb:e-host></sb:host><sb:comment>Accessed January 26, 2010</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>7</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Gregory</ce:surname></sb:author><sb:author><ce:given-name>R.W.</ce:given-name><ce:surname>Fitch</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sports medicine: performance-enhancing drugs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>797</sb:first-page><sb:last-page>806</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>8</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Goldman</ce:surname></sb:author><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Bush</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Klatz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Death in the locker room</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>1984</sb:date><sb:publisher><sb:name>Century</sb:name><sb:location>London</sb:location></sb:publisher></sb:book></sb:host><sb:comment>32</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>9</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Connor</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mazanov</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Would you dope? A general population test of the Goldman dilemma</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>43</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>871</sb:first-page><sb:last-page>872</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>10</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Talalay</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Talalay</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The importance of using scientific principles in the development of medicinal agents from plants</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acad Med</sb:maintitle></sb:title><sb:volume-nr>76</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>175</sb:first-page><sb:last-page>184</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>11</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Use and abuse of drugs and supplements</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>S.</ce:given-name><ce:surname>Bhave</ce:surname></sb:editor><sb:editor><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:editor><sb:editor><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Sports medicine</sb:maintitle></sb:title><sb:date>2008</sb:date><sb:publisher><sb:name>Jaypee Brothers Medical Publishers</sb:name><sb:location>New Delhi</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>122</sb:first-page><sb:last-page>133</sb:last-page></sb:pages></sb:host><sb:comment>Chapter 7</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>12</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sports doping in the adolescent athlete</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Asian J Paediatr Prac</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>9</sb:first-page><sb:last-page>14</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>13</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.M.</ce:given-name><ce:surname>Jenkinson</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Harbert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Supplments and sports</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am Fam Physician</sb:maintitle></sb:title><sb:volume-nr>78</sb:volume-nr></sb:series><sb:issue-nr>9</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1039</sb:first-page><sb:last-page>1046</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>14</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.H.</ce:given-name><ce:surname>Catlin</ce:surname></sb:author><sb:author><ce:given-name>K.D.</ce:given-name><ce:surname>Fitch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ljungqvist</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Medicine and science in the fight against doping in sport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Intern Med</sb:maintitle></sb:title><sb:volume-nr>264</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>99</sb:first-page><sb:last-page>114</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>15</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.C.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>McCambridge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Performance-enhancing substances in teens</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Contemp Pediatr</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:issue-nr>20</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>36</sb:first-page><sb:last-page>45</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>16</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Castillo</ce:surname></sb:author><sb:author><ce:given-name>R.D.</ce:given-name><ce:surname>Comstock</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Prevalence of use of performance-enhancing substances among United States adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>663</sb:first-page><sb:last-page>675</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>17</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Performance enhancing drugs and supplements</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:editor><sb:editor><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:editor><sb:editor><ce:given-name>R.</ce:given-name><ce:surname>Baker</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Pediatric practice: sports medicine</sb:maintitle></sb:title><sb:date>2009</sb:date><sb:publisher><sb:name>McGraw-Hill Medical Publishers</sb:name><sb:location>New York</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>63</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host><sb:comment>Chapter 7</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>18</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Wagner</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Enhancement of athletic performance with drugs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sports Med</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>150</sb:first-page><sb:last-page>165</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>19</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:surname>National Collegiate Athletic Association</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NCAA study of substance use and abuse habits of college student-athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>September, 1997</sb:date><sb:publisher><sb:name>NCAA Committee on Medical Safeguards and Medical Aspects of Sports</sb:name><sb:location>Indianapolis (IN)</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>20</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Petroczi</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Naughton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Supplement use in sport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Occup Med Toxicol</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>4</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>21</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Petroczi</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Naughton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The age-gender-status profile of high performing athletes taking nutritional supplements: lessons for the future</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Int Soc Sports Nutr</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>2</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>22</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.D.</ce:given-name><ce:surname>Armsey</ce:surname></sb:author><sb:author><ce:given-name>G.A.</ce:given-name><ce:surname>Green</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Nutrition supplements. Science vs. hype</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Phys Sportsmed</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>77</sb:first-page><sb:last-page>92</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>23</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.H.</ce:given-name><ce:surname>Catlin</ce:surname></sb:author><sb:author><ce:given-name>T.H.</ce:given-name><ce:surname>Murray</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Performance enhancing drugs, fair competition and Olympic sport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>231</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>24</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.M.</ce:given-name><ce:surname>Clarkson</ce:surname></sb:author><sb:author><ce:given-name>H.S.</ce:given-name><ce:surname>Thompson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Drugs and sport: research findings and limitations</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sports Med</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>366</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>25</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Sampson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The need for educational reform in teaching about alternative therapies</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acad Med</sb:maintitle></sb:title><sb:volume-nr>76</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>248</sb:first-page><sb:last-page>250</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>26</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.N.</ce:given-name><ce:surname>Chorley</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Dietary supplements as ergogenic agents</sb:maintitle></sb:title></sb:contribution><sb:comment>(American Academy of Pediatrics)</sb:comment><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Health Update</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>7</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>27</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.S.</ce:given-name><ce:surname>Volek</ce:surname></sb:author><sb:author><ce:given-name>W.J.</ce:given-name><ce:surname>Kraemer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Creatine supplementation: its effect on human muscular performance and body composition</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Strength Cond Res</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>200</sb:first-page><sb:last-page>210</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>28</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Branch</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Creatine supplementation and exercise performance: an update</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Nutr</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>216</sb:first-page><sb:last-page>234</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>29</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>H.D.</ce:given-name><ce:surname>Pratt</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Youth sports: more than sprains and strains</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Contemp Pediatr</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>45</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>30</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>H.D.</ce:given-name><ce:surname>Pratt</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sports and the neurodevelopment of the child and adolescent</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>J.C.</ce:given-name><ce:surname>DeLee</ce:surname></sb:editor><sb:editor><ce:given-name>D.D.</ce:given-name><ce:surname>Drez</ce:surname></sb:editor><sb:editor><ce:given-name>M.D.</ce:given-name><ce:surname>Miller</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Orthopaedics sports medicine</sb:maintitle></sb:title><sb:date>2003</sb:date><sb:publisher><sb:name>WB Saunders</sb:name><sb:location>Philadelphia</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>624</sb:first-page><sb:last-page>642</sb:last-page></sb:pages></sb:host><sb:comment>Chapter 17</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>31</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sports doping: use of drugs and supplements to enhance performance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Public Health J</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>7</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>32</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Dotson</ce:surname></sb:author><sb:author><ce:given-name>R.T.</ce:given-name><ce:surname>Brown</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The history of the development of anabolic-androgenic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>761</sb:first-page><sb:last-page>769</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>33</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Kerr</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Congeni</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic-androgenic steroids: use and abuse in pediatric patients</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>771</sb:first-page><sb:last-page>785</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>34</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Graham</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Davies</ce:surname></sb:author><sb:author><ce:given-name>F.M.</ce:given-name><ce:surname>Grace</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Anabolic steroid use: patterns of use and detection of doping</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sports Med</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>505</sb:first-page><sb:last-page>525</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>35</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Sj&ouml;qvist</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Garle</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rane</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Use of doping agents, particularly anabolic steroids, in sports and society</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>371</sb:volume-nr></sb:series><sb:issue-nr>9627</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1872</sb:first-page><sb:last-page>1882</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>36</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>W.E.</ce:given-name><ce:surname>Buckley</ce:surname></sb:author><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Yesalis</ce:surname><ce:suffix>III</ce:suffix></sb:author><sb:author><ce:given-name>K.E.</ce:given-name><ce:surname>Friedl</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Estimated prevalence of anabolic steroid use among male high school seniors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>260</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>3441</sb:first-page><sb:last-page>3446</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>37</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Faigenbaum</ce:surname></sb:author><sb:author><ce:given-name>L.D.</ce:given-name><ce:surname>Zaichkowsky</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Gardner</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Anabolic steroid use by male and female middle school students</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatrics</sb:maintitle></sb:title><sb:volume-nr>101</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>E6</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>38</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Foley</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schydlower</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroid and ergogenic drugs use by adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Med State Art Rev</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>341</sb:first-page><sb:last-page>352</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>39</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Jay</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Shoup</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Anabolic steroid use by male adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatrics</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>921</sb:first-page><sb:last-page>924</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>40</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Kindlundh</ce:surname></sb:author><sb:author><ce:given-name>D.G.</ce:given-name><ce:surname>Isacson</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Berglund</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Doping among high school students in Uppsala, Sweden: a presentation of the attitudes distribution, side effects, and extent of use</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Scand J Soc Med</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>71</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>41</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Komoroski</ce:surname></sb:author><sb:author><ce:given-name>V.I.</ce:given-name><ce:surname>Rickert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adolescent body image and attitudes to anabolic steroid use</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Dis Child</sb:maintitle></sb:title><sb:volume-nr>146</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>823</sb:first-page><sb:last-page>828</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>42</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Massad</ce:surname></sb:author><sb:author><ce:given-name>N.W.</ce:given-name><ce:surname>Shier</ce:surname></sb:author><sb:author><ce:given-name>D.M.</ce:given-name><ce:surname>Koceja</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>High school athletes and nutritional supplements: a study of knowledge and use</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Sport Nutr</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>232</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>43</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.B.</ce:given-name><ce:surname>Middleman</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Faulkner</ce:surname></sb:author><sb:author><ce:given-name>E.R.</ce:given-name><ce:surname>Woods</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>High-risk behaviors among high school students in Massachusetts who use anabolic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatrics</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>268</sb:first-page><sb:last-page>272</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>44</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The adolescent athlete</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>A.D.</ce:given-name><ce:surname>Hofmann</ce:surname></sb:editor><sb:editor><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Adolescent medicine</sb:maintitle></sb:title><sb:edition>3rd edition</sb:edition><sb:date>1997</sb:date><sb:publisher><sb:name>Appleton &amp; Lange</sb:name><sb:location>Stamford (CT)</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>607</sb:first-page><sb:last-page>638</sb:last-page></sb:pages></sb:host><sb:comment>Chapter 28</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>45</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Pope</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:author><ce:given-name>D.L.</ce:given-name><ce:surname>Katz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Psychiatric and medical effects of anabolic-androgenic steroid use</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Gen Psychiatry</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>375</sb:first-page><sb:last-page>382</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>46</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Tanner</ce:surname></sb:author><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Miller</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Aongi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin J Sport Med</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>109</sb:first-page><sb:last-page>115</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>47</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Rogal</ce:surname></sb:author><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Yesalis</ce:surname><ce:suffix>III</ce:suffix></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic-androgenic steroids and the adolescent</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Ann</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>175</sb:first-page><sb:last-page>188</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>48</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Sturmi</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Diorio</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic agents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>261</sb:first-page><sb:last-page>282</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>49</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Yesalis</ce:surname></sb:author><sb:author><ce:given-name>N.J.</ce:given-name><ce:surname>Kennedy</ce:surname></sb:author><sb:author><ce:given-name>A.N.</ce:given-name><ce:surname>Kopstein</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Anabolic-androgenic steroid use in the United States</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>270</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>1217</sb:first-page><sb:last-page>1221</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib50"><ce:label>50</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.H.</ce:given-name><ce:surname>DuRant</ce:surname></sb:author><sb:author><ce:given-name>V.I.</ce:given-name><ce:surname>Rickert</ce:surname></sb:author><sb:author><ce:given-name>C.S.</ce:given-name><ce:surname>Ashworth</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Use of multiple drugs among adolescents who use anabolic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>328</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>922</sb:first-page><sb:last-page>926</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib51"><ce:label>51</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.D.</ce:given-name><ce:surname>Johnston</ce:surname></sb:author><sb:author><ce:given-name>P.M.</ce:given-name><ce:surname>O&apos;Malley</ce:surname></sb:author><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Bachman</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Monitoring the future national results on adolescent drug use. Overview of key findings</sb:maintitle></sb:title></sb:contribution><sb:comment>NIH publication no. 09-7401</sb:comment><sb:host><sb:book><sb:date>2009</sb:date><sb:publisher><sb:name>National Institute on Drug Abuse</sb:name><sb:location>Bethesda (MD)</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib52"><ce:label>52</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.A.</ce:given-name><ce:surname>Harmer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic-androgenic steroid use among young male and female athletes: is the game to blame?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>26</sb:first-page><sb:last-page>31</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib53"><ce:label>53</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.H.</ce:given-name><ce:surname>DuRant</ce:surname></sb:author><sb:author><ce:given-name>L.G.</ce:given-name><ce:surname>Escobodo</ce:surname></sb:author><sb:author><ce:given-name>G.W.</ce:given-name><ce:surname>Heath</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroid use, strength training and multiple drug use among adolescents in the United States</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatrics</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>23</sb:first-page><sb:last-page>26</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib54"><ce:label>54</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.S.</ce:given-name><ce:surname>Heischober</ce:surname></sb:author><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Hofmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Substance abuse</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>A.D.</ce:given-name><ce:surname>Hofmann</ce:surname></sb:editor><sb:editor><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Adolescent medicine</sb:maintitle></sb:title><sb:edition>3rd edition</sb:edition><sb:date>1997</sb:date><sb:publisher><sb:name>Appleton &amp; Lange</sb:name><sb:location>Stamford (CT)</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>703</sb:first-page><sb:last-page>739</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib55"><ce:label>55</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schydlower</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Rogers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adolescent substance abuse and addictions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Med State Art Rev</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>227</sb:first-page><sb:last-page>477</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib56"><ce:label>56</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Substance abuse in adolescents: current concepts</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr Probl Pediatr Adolesc Health Care</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>78</sb:first-page><sb:last-page>98</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib57"><ce:label>57</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Substance abuse in adolescents: current concepts</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Disease-a-Month</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:issue-nr>7</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>392</sb:first-page><sb:last-page>431</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib58"><ce:label>58</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Josefson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Concern raised about performance enhancing drugs in the United States</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>BMJ</sb:maintitle></sb:title><sb:volume-nr>317</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>702</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib59"><ce:label>59</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:surname>American Academy of Pediatrics</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adolescents and anabolic steroids: a subject review. Committee on sports medicine and fitness</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatrics</sb:maintitle></sb:title><sb:volume-nr>99</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>7</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib60"><ce:label>60</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Brower</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Psychiatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>97</sb:first-page><sb:last-page>102</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib61"><ce:label>61</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Casavant</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Blake</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Griffith</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Consequences of use of anabolic androgenic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>677</sb:first-page><sb:last-page>690</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib62"><ce:label>62</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bhasin</ce:surname></sb:author><sb:author><ce:given-name>T.W.</ce:given-name><ce:surname>Storer</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Berman</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>335</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>7</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib63"><ce:label>63</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Kanayama</ce:surname></sb:author><sb:author><ce:given-name>J.I.</ce:given-name><ce:surname>Hudson</ce:surname></sb:author><sb:author><ce:given-name>H.G.</ce:given-name><ce:surname>Pope</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author></sb:authors><sb:title><sb:maintitle>Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Drug Alcohol Depend</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:issue-nr>1&ndash;2</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>12</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib64"><ce:label>64</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Blue</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Lombardo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Steroids and steroid-like compounds</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>667</sb:first-page><sb:last-page>689</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib65"><ce:label>65</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K.B.</ce:given-name><ce:surname>Kashkin</ce:surname></sb:author><sb:author><ce:given-name>H.D.</ce:given-name><ce:surname>Kleber</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hooked on hormones? An anabolic steroid addiction hypothesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>262</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>3166</sb:first-page><sb:last-page>3170</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib66"><ce:label>66</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Yesalis</ce:surname><ce:suffix>III</ce:suffix></sb:author><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Streit</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Vicary</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Anabolic sterid use: indications of habituation among adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Drug Educ</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>103</sb:first-page><sb:last-page>116</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib67"><ce:label>67</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Duclos</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Use, abuse, and biomedical detection of anabolic steroids and glucocorticoids in sports</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Endocrinol (Paris)</sb:maintitle></sb:title><sb:volume-nr>68</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>308</sb:first-page><sb:last-page>314</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib68"><ce:label>68</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Malone</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Dimeff</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Lombardo</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin J Sport Med</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>25</sb:first-page><sb:last-page>31</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib69"><ce:label>69</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hypercholesterolemia in male power lifters using anabolic-androgenic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Phys Sportsmed</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>49</sb:first-page><sb:last-page>59</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib70"><ce:label>70</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.D.</ce:given-name><ce:surname>Dickerman</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Schaller</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Prather</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden cardiac death in a 20-year old bodybuilder using anabolic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiology</sb:maintitle></sb:title><sb:volume-nr>86</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>172</sb:first-page><sb:last-page>173</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib71"><ce:label>71</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>G.S.</ce:given-name><ce:surname>Ferenchick</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Are androgenic steroids thrombogenic?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>322</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>476</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib72"><ce:label>72</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Fisher</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Applyby</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Rittoo</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Clin Pract</sb:maintitle></sb:title><sb:volume-nr>50</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>222</sb:first-page><sb:last-page>223</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib73"><ce:label>73</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.C.</ce:given-name><ce:surname>Kennedy</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Lawrence</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroid abuse and cardiac death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med J Aust</sb:maintitle></sb:title><sb:volume-nr>158</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>346</sb:first-page><sb:last-page>348</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib74"><ce:label>74</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Luckstead</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Use and abuse of drugs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Medical care of the athlete</sb:maintitle></sb:title><sb:date>1993</sb:date><sb:publisher><sb:name>Practice Management Information Corp</sb:name><sb:location>Los Angeles</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>195</sb:first-page><sb:last-page>205</sb:last-page></sb:pages></sb:host><sb:comment>Chapter 8</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib75"><ce:label>75</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author><sb:author><ce:given-name>H.D.</ce:given-name><ce:surname>Pratt</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Psychosocial considerations for the adolescent athlete: lessons learned from the United States experience</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Asian J Paediatr Prac</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>19</sb:first-page><sb:last-page>29</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib76"><ce:label>76</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>H.D.</ce:given-name><ce:surname>Pratt</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Greydanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adolescent growth, development and psychosocial aspects of sports participation: an overview</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Med State Art Rev</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>425</sb:first-page><sb:last-page>440</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib77"><ce:label>77</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Goldberg</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>MacKinnon</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Elliot</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The Adolescent Training and Learning to Avoid Steroids Program: preventing drug use and promoting health behaviors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Pediatr Adolesc Med</sb:maintitle></sb:title><sb:volume-nr>154</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>332</sb:first-page><sb:last-page>338</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib78"><ce:label>78</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Goldberg</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Elliot</ce:surname></sb:author><sb:author><ce:given-name>G.N.</ce:given-name><ce:surname>Clark</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The Adolescent Training and Learning to Avoid Steroids (ATLAS) Program: effects of a multidimensional anabolic steroid prevention intervention</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1555</sb:first-page><sb:last-page>1562</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib79"><ce:label>79</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Dobs</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Is there a role for androgenic anabolic steroids in medical practice?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>281</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1326</sb:first-page><sb:last-page>1327</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib80"><ce:label>80</ce:label><sb:reference><sb:contribution><sb:title><sb:maintitle>Creatine and androstenedione&mdash;two &ldquo;dietary supplements&rdquo;</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Lett Drugs Ther</sb:maintitle></sb:title><sb:volume-nr>40</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>105</sb:first-page><sb:last-page>106</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib81"><ce:label>81</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Nestler</ce:surname></sb:author><sb:author><ce:given-name>C.O.</ce:given-name><ce:surname>Barlascini</ce:surname></sb:author><sb:author><ce:given-name>J.N.</ce:given-name><ce:surname>Clore</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat, but does not alter insulin sensitivity in normal men</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Clin Endocrinol Metab</sb:maintitle></sb:title><sb:volume-nr>66</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>57</sb:first-page><sb:last-page>61</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib82"><ce:label>82</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Broeder</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Quindry</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Brittingham</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The Andro Project</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Intern Med</sb:maintitle></sb:title><sb:volume-nr>160</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>3093</sb:first-page><sb:last-page>3104</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib83"><ce:label>83</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>W.A.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:author><ce:given-name>G.L.</ce:given-name><ce:surname>Landry</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Nutritional supplements: fact vs fiction</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Med State Art Rev</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>501</sb:first-page><sb:last-page>513</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib84"><ce:label>84</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Di Luigi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Supplements and the endocrine system in athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>131</sb:first-page><sb:last-page>151</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib85"><ce:label>85</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Smurawa</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Congeni</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tesosterone precursors: use and abuse in pediatric athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>787</sb:first-page><sb:last-page>796</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib86"><ce:label>86</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Anabolic steroid use in adolescent athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>37</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>111</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib87"><ce:label>87</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Buzzini</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Abuse of growth hormone among young athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>823</sb:first-page><sb:last-page>843</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib88"><ce:label>88</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Erotokritou-Mulligan</ce:surname></sb:author><sb:author><ce:given-name>E.E.</ce:given-name><ce:surname>Bassett</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Kniess</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Growth Horm IGF Res</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>416</sb:first-page><sb:last-page>423</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib89"><ce:label>89</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Kamboj</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Abuse of growth hormone by athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Intern Public Health J</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>10</sb:first-page><sb:last-page>18</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib90"><ce:label>90</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Lattavo</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Kopperud</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Rogers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Creatine and other supplements</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>735</sb:first-page><sb:last-page>760</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib91"><ce:label>91</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.E.</ce:given-name><ce:surname>Denham</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Association between narcotic use and anabolic-androgenic steroid use among American adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Subst Use Misuse</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:issue-nr>14</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>2043</sb:first-page><sb:last-page>2061</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib92"><ce:label>92</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.K.</ce:given-name><ce:surname>Parr</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Koehler</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Geyer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Clenbuterol marketed as dietary supplement</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biomed Chromatogr</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>298</sb:first-page><sb:last-page>300</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib93"><ce:label>93</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Beckett</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Clenbuterol and sport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>340</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>1165</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib94"><ce:label>94</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>Roberts</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The impact of long-term clenbuterol on athletic performance in horses</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Vet J</sb:maintitle></sb:title><sb:volume-nr>182</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>377</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib95"><ce:label>95</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Hilderbrand</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The world anti-doping program and the primary care physician</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>701</sb:first-page><sb:last-page>711</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib96"><ce:label>96</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Barroso</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Mazzoni</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Rabin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hormone abuse in sports: the antidoping perspective</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Asian J Androl</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>391</sb:first-page><sb:last-page>402</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib97"><ce:label>97</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Alaranta</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Alaranta</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Helenius</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Use of prescription drugs in athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sports med</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>449</sb:first-page><sb:last-page>463</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib98"><ce:label>98</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:surname>The National Collegiate Athletic Association</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NCAA study of substance use and abuse habits of college student-athletes</sb:maintitle></sb:title></sb:contribution><sb:comment>Available at:</sb:comment><sb:host><sb:e-host><ce:inter-ref xlink:href="http://www.ncaa.org/sports_sciences/education/199709abuse.pdft">http://www.ncaa.org/sports_sciences/education/199709abuse.pdft</ce:inter-ref></sb:e-host></sb:host><sb:comment>Assessed February 15, 2010</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib99"><ce:label>99</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.R.</ce:given-name><ce:surname>Stricker</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Other ergogenic agents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>283</sb:first-page><sb:last-page>297</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib100"><ce:label>100</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>Clark</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Creatine and phosphocreatine: a review of their use in exercise and sport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Journal of Athletic Training</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>45</sb:first-page><sb:last-page>51</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib101"><ce:label>101</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Engelhardt</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Neumann</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Berbalk</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Creatine supplementation in endurance sports</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1123</sb:first-page><sb:last-page>1129</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib102"><ce:label>102</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Greenhaff</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Creatine and its application as an ergogenic aid</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Sport Nutr</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>S100</sb:first-page><sb:last-page>S110</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib103"><ce:label>103</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Grindstaff</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Sport Nutr</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>330</sb:first-page><sb:last-page>346</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib104"><ce:label>104</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Petroczi</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Naughton</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mazanov</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Performance enhancement with supplements: incongruence between rationale and practice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Int Soc Sports Nutr</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>19</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib105"><ce:label>105</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Brannon</ce:surname></sb:author><sb:author><ce:given-name>G.R.</ce:given-name><ce:surname>Adams</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Conniff</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Effects of creatine loading and training on running performance and biochemical properties of rat skeletal muscle</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>489</sb:first-page><sb:last-page>495</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib106"><ce:label>106</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.L.</ce:given-name><ce:surname>Greenhaff</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Casey</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Short</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Influence of oral creatine supplementation on muscle torque during repeated bouts of maximal voluntary exercise for men</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sci</sb:maintitle></sb:title><sb:volume-nr>84</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>565</sb:first-page><sb:last-page>571</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib107"><ce:label>107</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Williams</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Nutritional ergogenics and sports performance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>The President&apos;s Council on Physical Fitness and Sports Research Digest</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>8</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib108"><ce:label>108</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.M.</ce:given-name><ce:surname>Burke</ce:surname></sb:author><sb:author><ce:given-name>D.B.</ce:given-name><ce:surname>Pyne</ce:surname></sb:author><sb:author><ce:given-name>R.D.</ce:given-name><ce:surname>Telford</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Effect of oral creatine supplementation on single effort sprint performance in elite runners</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int J Sport Nutr</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>222</sb:first-page><sb:last-page>233</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib109"><ce:label>109</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>W.H.</ce:given-name><ce:surname>Cooke</ce:surname></sb:author><sb:author><ce:given-name>P.W.</ce:given-name><ce:surname>Grandjean</ce:surname></sb:author><sb:author><ce:given-name>W.S.</ce:given-name><ce:surname>Barnes</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Effect of oral creatine supplementation on power output and fatigue during bicycle ergometry</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Appl Physiol</sb:maintitle></sb:title><sb:volume-nr>78</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>670</sb:first-page><sb:last-page>673</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib110"><ce:label>110</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Mujika</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Chatard</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Lacoste</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Creatine supplementation does not improve sprint performance in competitive swimmers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1435</sb:first-page><sb:last-page>1441</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib111"><ce:label>111</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Graef</ce:surname></sb:author><sb:author><ce:given-name>A.E.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:author><ce:given-name>K.L.</ce:given-name><ce:surname>Kendall</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The effects of four weeks of creatine supplementation and high-intensity interval training on cardiorespiratory fitness: a randomized controlled trial. J Int Soc Sports Nutr</sb:maintitle></sb:title></sb:contribution><sb:comment>6:18. Available at:</sb:comment><sb:host><sb:e-host><ce:inter-ref xlink:href="http://www.jissn.com/content/6/1/18">http://www.jissn.com/content/6/1/18</ce:inter-ref></sb:e-host></sb:host><sb:comment>Accessed January 20, 2010</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib112"><ce:label>112</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Cristani</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Romagnoli</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Boldrini</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sport&apos;s medicalization</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Recenti Prog Med</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:issue-nr>9</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>433</sb:first-page><sb:last-page>436</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib113"><ce:label>113</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Harris</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Sderlund</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hultman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Elevation of creatine in resting and exercise muscles of normal subjects by creatine supplementation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sci</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>367</sb:first-page><sb:last-page>374</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib114"><ce:label>114</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hultman</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Sderlund</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Timmons</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Muscle creatine loading in men</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Appl Physiol</sb:maintitle></sb:title><sb:volume-nr>81</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>232</sb:first-page><sb:last-page>237</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib115"><ce:label>115</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Terjung</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Clarkson</ce:surname></sb:author><sb:author><ce:given-name>E.R.</ce:given-name><ce:surname>Eichner</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>American College of Sports Medicine roundtable. Physiological and health effects of oral creatine supplementation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>706</sb:first-page><sb:last-page>717</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib116"><ce:label>116</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Keisler</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Hosey</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ergogenic aids: an update on ephedra</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr Sports Med Rep</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>231</sb:first-page><sb:last-page>235</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib117"><ce:label>117</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bent</ce:surname></sb:author><sb:author><ce:given-name>T.N.</ce:given-name><ce:surname>Tiedt</ce:surname></sb:author><sb:author><ce:given-name>M.C.</ce:given-name><ce:surname>Odden</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The relative safety of ephedra compared to other herbal products</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle></sb:title><sb:volume-nr>138</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>468</sb:first-page><sb:last-page>471</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib118"><ce:label>118</ce:label><ce:other-ref><ce:textref>FDA proposes safety measures for ephedrine dietary supplements. US Department of Health and Human Services News, June 2, 1997.</ce:textref></ce:other-ref></ce:bib-reference><ce:bib-reference id="bib119"><ce:label>119</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>L.M.</ce:given-name><ce:surname>Burke</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Caffeine and sports performance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Appl Physiol Nutr Metabol</sb:maintitle></sb:title><sb:volume-nr>33</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1319</sb:first-page><sb:last-page>1334</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib120"><ce:label>120</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Tarnopolsky</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Protein, caffeine and sports: guidelines for active people</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Phys Sportsmed</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>137</sb:first-page><sb:last-page>149</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib121"><ce:label>121</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.L.</ce:given-name><ce:surname>Pommering</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Erythropoietin and other blood-boosting methods</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>691</sb:first-page><sb:last-page>699</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib122"><ce:label>122</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:surname>American College of Sports Medicine</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Position stand on the use of blood doping as an ergogenic aid</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib123"><ce:label>123</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Thevis</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Schanzer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mass spectrometric determination of insulins and their degradation products in sports drug testing</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mass Spectrom Rev</sb:maintitle></sb:title></sb:series><sb:date>2007</sb:date></sb:issue></sb:host><sb:comment>Available at:</sb:comment><sb:host><sb:e-host><ce:inter-ref xlink:href="http://dopingjournal.org/noteworthy/achive/2007_11_01%3Carchive.html">http://dopingjournal.org/noteworthy/achive/2007_11_01&lt;archive.html</ce:inter-ref></sb:e-host></sb:host><sb:comment>Accessed January 26, 2010</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib124"><ce:label>124</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Thevis</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Kohler</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Maurer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Rapid Commun Mass Spectrom</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:issue-nr>21</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>3477</sb:first-page><sb:last-page>3486</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib125"><ce:label>125</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Powers</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hamilton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Antioxidants and exercise</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin Sports Med</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>525</sb:first-page><sb:last-page>536</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib126"><ce:label>126</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Luckstead</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sport participation, risk taking and health risk behaviors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adolesc Med State Art Rev</sb:maintitle></sb:title><sb:volume-nr>11</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>78</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib127"><ce:label>127</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Petr&oacute;czi</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Naughton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Popular drugs in sports: descriptive analysis of the enquiries made via the Drug Information Database (DID)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>43</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>811</sb:first-page><sb:last-page>817</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib128"><ce:label>128</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Martinsen</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bratland-Sanda</ce:surname></sb:author><sb:author><ce:given-name>A.K.</ce:given-name><ce:surname>Eriksson</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Dieting to win to be thin? A&nbsp;study of dieting and disordered eating among adolescent elite athletes and non-athlete controls</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>70</sb:first-page><sb:last-page>76</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>